col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


622 Results       Page 1

 [1] 
Proceedings of the National Academy of Sciences: Proceedings of the National Academy of Sciences
  original article Date Title Authors   All Authors
1 [GO] 2024―Aug―07 In-person learning during the pandemic: Student take-up and school-level effects of remote and hybrid instruction on student outcomes Stephen L. Ross, Shangyue Jiang, Michael F. Young, Joanna L. Meyer, Michael J. Strambler
2 [GO] 2024―Jul―31 Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses Wei Zhang, Ke Shi, Fu-Chun Hsueh, Alise Mendoza, Gang Ye, Linfen Huang, et al. (+3)
3 [GO] 2024―Jul―23 SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells Stephanie A. Gaglione, Tatiana J. Rosales, Laura Schmidt-Hong, Brian M. Baker, Michael E. Birnbaum
4 [GO] 2024―Jul―19 A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response Sandra L. Leibel, Rachael N. McVicar, Rabi Murad, Elizabeth M. Kwong, Alex E. Clark, Asuka Alvarado, et al. (+22)
5 [GO] 2024―Jul―15 Mitochondrial antioxidants abate SARS-COV-2 pathology in mice Joseph W. Guarnieri, Timothy Lie, Yentli E. Soto Albrecht, Peter Hewin, Kellie A. Jurado, Gabrielle A. Widjaja, et al. (+9)
6 [GO] 2024―Jul―11 Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2 Cristina Ferrer-Orta, Sergi Vázquez-Monteagudo, Diego S. Ferrero, Brenda Martínez-González, Celia Perales, Esteban Domingo, Nuria Verdaguer
7 [GO] 2024―Jul―08 Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays Zhe Hu, Alberto Domingo López-Muñoz, Ivan Kosik, Tiansheng Li, Victoria Callahan, Kelsie Brooks, et al. (+10)
8 [GO] 2024―Jul―05 SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening Qinghua Wu, Naimeh Rafatian, Karl T. Wagner, Jacob Blamer, Jacob Smith, Sargol Okhovatian, et al. (+22)
9 [GO] 2024―Jun―17 The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic Daniel Tortorice, Rino Rappuoli, David E. Bloom
10 [GO] 2024―Jun―11 Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification Tjibbe Donker, Alexis Papathanassopoulos, Hiren Ghosh, Raisa Kociurzynski, Marius Felder, Hajo Grundmann, Sandra Reuter
11 [GO] 2024―Jun―06 SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection Jaresley V. Guillen, Britt A. Glaunsinger
12 [GO] 2024―Jun―04 Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses Yuan-Ting Guo, Ji-Bin Jiang, Guan-Rong Qiao, Rong-Hua Luo, Xin Zhou, Rong Hua, et al. (+2)
13 [GO] 2024―May―31 Biophysical principles predict fitness of SARS-CoV-2 variants Dianzhuo Wang, Marian Huot, Vaibhav Mohanty, Eugene I. Shakhnovich
14 [GO] 2024―May―20 Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis Menghan Mei, Anastasija Cupic, Lisa Miorin, Chengjin Ye, Tolga Cagatay, Ke Zhang, et al. (+12)
15 [GO] 2024―May―17 Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance Clayton J. Otter, David M. Renner, Alejandra Fausto, Li Hui Tan, Noam A. Cohen, Susan R. Weiss
16 [GO] 2024―May―15 Declining Chinese attitudes toward the United States amid COVID-19 Yu Xie, Feng Yang, Junming Huang, Yuchen He, Yi Zhou, Yue Qian, et al. (+2)
17 [GO] 2024―May―09 Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1 Maryann Morales, Moon Young Yang, William A. Goddard, Harry B. Gray, Jay R. Winkler
18 [GO] 2024―Apr―25 Correction for Howard et al., An evidence review of face masks against COVID-19
19 [GO] 2024―Apr―22 Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis Claryn S. J. Kung, Andrew Steptoe
20 [GO] 2024―Apr―17 Inferring COVID-19 testing and vaccination behavior from New Jersey testing data Ari S. Freedman, Justin K. Sheen, Stella Tsai, Jihong Yao, Edward Lifshitz, David Adinaro, et al. (+3)
21 [GO] 2024―Apr―17 Substantial transmission of SARS-CoV-2 through casual contact in retail stores: Evidence from matched administrative microdata on card payments and testing Niels Johannesen, Alessandro Tang-Andersen Martinello, Bjørn Bjørnsson Meyer, Emil Toft Vestergaard, Asger Lau Andersen, Thais Lærkholm Jensen
22 [GO] 2024―Apr―15 Correction for Espinoza et al., Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions
23 [GO] 2024―Apr―03 SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling Clayton J. Otter, Nicole Bracci, Nicholas A. Parenti, Chengjin Ye, Abhishek Asthana, Ebba K. Blomqvist, et al. (+9)
24 [GO] 2024―Apr―01 Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike Timothy J. C. Tan, Abhishek K. Verma, Abby Odle, Ruipeng Lei, David K. Meyerholz, Kenneth A. Matreyek, et al. (+3)
25 [GO] 2024―Mar―19 Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants Rui Gao, Xinxin Xu, Prashant Kumar, Ye Liu, Hongyu Zhang, Xiao Guo, et al. (+11)
26 [GO] 2024―Mar―19 Elucidating the behavior of the SARS-CoV-2 virus surface at vapor-liquid interfaces using molecular dynamics simulation Florian Fleckenstein, Simon Stephan, Hans Hasse
27 [GO] 2024―Mar―13 Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods Roberto Cahuantzi, Katrina A. Lythgoe, Ian Hall, Lorenzo Pellis, Thomas House
28 [GO] 2024―Mar―01 Tertiary folds of the SL5 RNA from the 5′ proximal region of SARS-CoV-2 and related coronaviruses Rachael C. Kretsch, Lily Xu, Ivan N. Zheludev, Xueting Zhou, Rui Huang, Grace Nye, et al. (+4)
29 [GO] 2024―Feb―28 Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps Soledad Delgado, Pilar Somovilla, Cristina Ferrer-Orta, Brenda Martínez-González, Sergi Vázquez-Monteagudo, Javier Muñoz-Flores, et al. (+11)
30 [GO] 2024―Feb―26 Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform Soojeong Chang, Kwang-Soo Shin, Bongju Park, Seowoo Park, Jieun Shin, Hyemin Park, et al. (+10)
31 [GO] 2024―Feb―26 Human transferrin receptor can mediate SARS-CoV-2 infection Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zilei Duan, Lei Liu, et al. (+16)
32 [GO] 2024―Feb―15 US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions Stephen A. Rains, Adam S. Richards
33 [GO] 2024―Feb―02 Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes Yue Zhang, Vanthana Bharathi, Tatsuya Dokoshi, Jaime de Anda, Lauryn Tumey Ursery, Nikhil N. Kulkarni, et al. (+29)
34 [GO] 2024―Feb―01 Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths Eugenio Paglino, Dielle J. Lundberg, Elizabeth Wrigley-Field, Zhenwei Zhou, Joe A. Wasserman, Rafeya Raquib, et al. (+6)
35 [GO] 2024―Jan―18 Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization Tae Yeon Yoo, Timothy J. Mitchison
36 [GO] 2024―Jan―12 On the surprising effectiveness of a simple matrix exponential derivative approximation, with application to global SARS-CoV-2 Gustavo Didier, Nathan E. Glatt-Holtz, Andrew J. Holbrook, Andrew F. Magee, Marc A. Suchard
37 [GO] 2024―Jan―10 High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies Ida Paciello, Giuseppe Maccari, Elisa Pantano, Emanuele Andreano, Rino Rappuoli
38 [GO] 2024―Jan―09 Higher chronic absenteeism threatens academic recovery from the COVID-19 pandemic Thomas S. Dee
39 [GO] 2024―Jan―04 Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data Timothy G. Vaughan, Jérémie Scire, Sarah A. Nadeau, Tanja Stadler
40 [GO] 2023―Dec―26 A simplicial epidemic model for COVID-19 spread analysis Yuzhou Chen, Yulia R. Gel, Madhav V. Marathe, H. Vincent Poor
41 [GO] 2023―Dec―22 Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection Sho Miyamoto, Takara Nishiyama, Akira Ueno, Hyeongki Park, Takayuki Kanno, Naotoshi Nakamura, et al. (+36)
42 [GO] 2023―Dec―22 Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants Zhongfeng Ye, Srinivasa Reddy Bonam, Lindsay G. A. McKay, Jessica A. Plante, Jordyn Walker, Yu Zhao, et al. (+14)
43 [GO] 2023―Dec―18 Correction for Venter et al., COVID-19 lockdowns cause global air pollution declines
44 [GO] 2023―Dec―18 Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 Xia Rao, Runchu Zhao, Zhou Tong, Shuxin Guo, Weiyu Peng, Kefang Liu, et al. (+19)
45 [GO] 2023―Dec―07 Integrin α 5 β 1 contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction Heng Zhang, Zhengli Wang, Huong T. T. Nguyen, Abigail J. Watson, Qifang Lao, An Li, Jieqing Zhu
46 [GO] 2023―Nov―27 The impact of COVID-19 on a college freshman sample reveals genetic and nongenetic forms of susceptibility and resilience to stress Cortney A. Turner, Huzefa Khalil, Virginia Murphy-Weinberg, Megan H. Hagenauer, Linda Gates, Yu Tang, et al. (+11)
47 [GO] 2023―Nov―27 Vaccination, immunity, and the changing impact of COVID-19 on infant health Florencia Torche, Jenna Nobles
48 [GO] 2023―Nov―27 Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA) Cheng-Wei Cheng, Chung-Yi Wu, Szu-Wen Wang, Jia-Yan Chen, Chih-Chuan Kung, Kuo-Shiang Liao, Chi-Huey Wong
49 [GO] 2023―Nov―20 Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions Baltazar Espinoza, Aniruddha Adiga, Srinivasan Venkatramanan, Andrew Scott Warren, Jiangzhuo Chen, Bryan Leroy Lewis, et al. (+12)
50 [GO] 2023―Nov―14 Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates Yongzhi Chen, Xuqiu Lei, Zhaozhao Jiang, Fiachra Humphries, Krishna Mohan Parsi, Nicholas J. Mustone, et al. (+6)
51 [GO] 2023―Nov―09 Inequality and COVID-19 in Sweden: Relative risks of nine bad life events, by four social gradients, in pandemic vs. prepandemic years Adam Altmejd, Olof Östergren, Evelina Björkegren, Torsten Persson
52 [GO] 2023―Oct―09 Frailty and survival in the 1918 influenza pandemic Amanda Wissler, Sharon N. DeWitte
53 [GO] 2023―Oct―05 A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern Jiayu Xu, Yuexiu Zhang, Panke Qu, Mohamed M. Shamseldin, Sung J. Yoo, Jack Misny, et al. (+17)
54 [GO] 2023―Oct―03 Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study William S. Hart, Hyeongki Park, Yong Dam Jeong, Kwang Su Kim, Raiki Yoshimura, Robin N. Thompson, Shingo Iwami
55 [GO] 2023―Oct―02 Policy instruments facilitate China’s COVID-19 work resumption Pengjun Zhao, Qiyang Liu, Tianyu Ma, Tingting Kang, Zhengzi Zhou, Zhengying Liu, et al. (+2)
56 [GO] 2023―Sep―25 Reply to Ekström and Ottersen: Real-time access to data during outbreaks is a key to avoid a local epidemic becoming a global pandemic Nils Chr. Stenseth, Rudolf Schlatte, Xiaoli Liu, Roger Pielke, Bin Chen, Ottar N. Bjørnstad, et al. (+7)
57 [GO] 2023―Sep―25 Digital twin for pandemic monitoring and prevention: Urgent need for agreements for global data sharing Anna Mia Ekström, Ole Petter Ottersen
58 [GO] 2023―Sep―18 The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2 Ruiqi Huang, Gabrielle Warner Jenkins, Yunjeong Kim, Robyn L. Stanfield, Amrinder Singh, Maria Martinez-Yamout, et al. (+30)
59 [GO] 2023―Sep―11 Targeting spike glycans to inhibit SARS-CoV2 viral entry Alex J. Guseman, Linda J. Rennick, Sham Nambulli, Chandra N. Roy, David R. Martinez, Darian T. Yang, et al. (+7)
60 [GO] 2023―Sep―05 Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease Haiyu Xu, Yute Zhong, Jinyue Yang, Lifeng Fu, Yi Shi, Luqi Huang, George F. Gao
61 [GO] 2023―Sep―05 Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease Haohao Yan, Rui Zhang, Xiaoping Liu, Yanchang Wang, Yunyu Chen
62 [GO] 2023―Aug―22 SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, Catherine M. Kerr, Joseph J. O’Connor, Jessica J. Pfannenstiel, et al. (+10)
63 [GO] 2023―Aug―21 IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding Marcus J. Bolton, Jefferson J. S. Santos, Claudia P. Arevalo, Trevor Griesman, Megan Watson, Shuk Hang Li, et al. (+4)
64 [GO] 2023―Aug―15 The COVID-19 baby bump in the United States Martha J. Bailey, Janet Currie, Hannes Schwandt
65 [GO] 2023―Aug―09 Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines Sarah J. Shepherd, Xuexiang Han, Alvin J. Mukalel, Rakan El-Mayta, Ajay S. Thatte, Jingyu Wu, et al. (+7)
66 [GO] 2023―Aug―08 An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities Nunziata Maio, Md Kausar Raza, Yan Li, De-Liang Zhang, J. Martin Bollinger, Carsten Krebs, Tracey A. Rouault
67 [GO] 2023―Aug―07 Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2 Lingyue Yang, Zengmiao Wang, Lin Wang, Bram Vrancken, Ruixue Wang, Yuanlong Wei, et al. (+13)
68 [GO] 2023―Aug―01 Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations Alyssa M. Bilinski, Joshua A. Salomon, Laura A. Hatfield
69 [GO] 2023―Jul―31 SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates Stefanie M. Bader, James P. Cooney, Dylan Sheerin, George Taiaroa, Leigh Harty, Kathryn C. Davidson, et al. (+18)
70 [GO] 2023―Jul―25 Separating signal from noise in wastewater data: An algorithm to identify community-level COVID-19 surges in real time Aparna Keshaviah, Ian Huff, Xindi C. Hu, Virginia Guidry, Ariel Christensen, Steven Berkowitz, et al. (+7)
71 [GO] 2023―Jul―24 Reminders, but not monetary incentives, increase COVID-19 booster uptake Tom Y. Chang, Mireille Jacobson, Manisha Shah, Matthew Kopetsky, Rajiv Pramanik, Samir B. Shah
72 [GO] 2023―Jul―24 Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence Pengfei Li, Biyun Xue, Nicholas J. Schnicker, Lok-Yin Roy Wong, David K. Meyerholz, Stanley Perlman
73 [GO] 2023―Jul―19 H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic Mengying Liu, A. Sophie Bakker, Yoshiki Narimatsu, Frank J. M. van Kuppeveld, Henrik Clausen, Cornelis A. M. de Haan, Erik de Vries
74 [GO] 2023―Jul―19 Mink farming poses risks for future viral pandemics Thomas P. Peacock, Wendy S. Barclay
75 [GO] 2023―Jul―17 A variant-dependent molecular clock with anomalous diffusion models SARS-CoV-2 evolution in humans Lucas Goiriz, Raúl Ruiz, Òscar Garibo-i-Orts, J. Alberto Conejero, Guillermo Rodrigo
76 [GO] 2023―Jul―17 Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response Yuanyuan Qiao, Jesse W. Wotring, Yang Zheng, Charles J. Zhang, Yuping Zhang, Xia Jiang, et al. (+16)
77 [GO] 2023―Jul―10 Correction for Li et al., SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes
78 [GO] 2023―Jul―10 Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles Peng Zhang, Samantha Falcone, Yaroslav Tsybovsky, Mamta Singh, Vinay Gopan, Huiyi Miao, et al. (+10)
79 [GO] 2023―Jul―03 Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics Pragati V. Prasad, Molly K. Steele, Carrie Reed, Lauren Ancel Meyers, Zhanwei Du, Remy Pasco, et al. (+22)
80 [GO] 2023―Jun―20 A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein Vito Thijssen, Daniel L. Hurdiss, Oliver J. Debski-Antoniak, Matthew A. Spence, Charlotte Franck, Alexander Norman, et al. (+17)
81 [GO] 2023―Jun―20 Idiosyncratic media exposures during a pandemic and their link to well-being, cognition, and behavior over time Nickolas M. Jones, Rebecca R. Thompson, E. Alison Holman, Roxane Cohen Silver
82 [GO] 2023―Jun―12 An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo Kuo Liu, Muxue Tang, Wei Xu, Xinfeng Meng, Hengwei Jin, Maoying Han, et al. (+8)
83 [GO] 2023―Jun―07 Individual costs and societal benefits of interventions during the COVID-19 pandemic Arne Traulsen, Simon A. Levin, Chadi M. Saad-Roy
84 [GO] 2023―May―30 Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model Takuya Tada, Julia Minnee, Nathaniel R. Landau
85 [GO] 2023―May―30 Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection Jamie Guenthoer, Michelle Lilly, Tyler N. Starr, Bernadeta Dadonaite, Klaus N. Lovendahl, Jacob T. Croft, et al. (+10)
86 [GO] 2023―May―23 Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection Marvin Petersen, Felix Leonard Nägele, Carola Mayer, Maximilian Schell, Elina Petersen, Simone Kühn, et al. (+9)
87 [GO] 2023―May―22 Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19 Tadashi Hosoya, Seiya Oba, Yoji Komiya, Daisuke Kawata, Mari Kamiya, Hideyuki Iwai, et al. (+16)
88 [GO] 2023―May―22 Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2 Sang Woo Park, Kaiyuan Sun, Sam Abbott, Ron Sender, Yinon M. Bar-on, Joshua S. Weitz, et al. (+6)
89 [GO] 2023―May―15 COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis Ester A. Barreto, Amanda S. Cruz, Flavio P. Veras, Ronaldo Martins, Rafaella S. Bernardelli, Isadora M. Paiva, et al. (+24)
90 [GO] 2023―May―08 Evolution of coronavirus frameshifting elements: Competing stem networks explain conservation and variability Shuting Yan, Qiyao Zhu, Jenna Hohl, Alex Dong, Tamar Schlick
91 [GO] 2023―May―01 Monitoring and addressing the long-term impacts of the COVID-19 pandemic on women in academic science, engineering, and medicine Marie Harton, Terri Goss Kinzy, Ashley Bear
92 [GO] 2023―May―01 Three years of COVID-19 and life satisfaction in Europe: A macro view Richard A. Easterlin, Kelsey J. O’Connor
93 [GO] 2023―Apr―24 Correction for Arpino et al., COVID-19 precautionary behaviors and vaccine acceptance among older individuals: The role of close kin
94 [GO] 2023―Apr―24 Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19 Haiyu Xu, Shufen Li, Jiayuan Liu, Jinlong Cheng, Liping Kang, Weijie Li, et al. (+27)
95 [GO] 2023―Apr―24 In situ architecture and membrane fusion of SARS-CoV-2 Delta variant Yutong Song, Hangping Yao, Nanping Wu, Jialu Xu, Zheyuan Zhang, Cheng Peng, et al. (+10)
96 [GO] 2023―Apr―17 Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants Cun Li, Jingjing Huang, Yifei Yu, Zhixin Wan, Man Chun Chiu, Xiaojuan Liu, et al. (+11)
97 [GO] 2023―Apr―17 Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission Jialin Zhang, Wenyu Yang, Sawrab Roy, Heidi Liu, R. Michael Roberts, Liping Wang, et al. (+2)
98 [GO] 2023―Apr―10 Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants Miyu Moriyama, Carolina Lucas, Valter Silva Monteiro, Akiko Iwasaki, Nicholas Chen, Mallery Breban, et al. (+15)
99 [GO] 2023―Apr―06 Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses Clayton J. Otter, Alejandra Fausto, Li Hui Tan, Alisha S. Khosla, Noam A. Cohen, Susan R. Weiss
100 [GO] 2023―Apr―04 Correction for Cramer et al., Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States
101 [GO] 2023―Mar―20 COVID-19 precautionary behaviors and vaccine acceptance among older individuals: The role of close kin Bruno Arpino, Valeria Bordone, Giorgio Di Gessa
102 [GO] 2023―Mar―20 Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor Kailu Yang, Chuchu Wang, Alex J. B. Kreutzberger, K. Ian White, Richard A. Pfuetzner, Luis Esquivies, et al. (+2)
103 [GO] 2023―Mar―14 Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age Marion Humbert, Anna Olofsson, David Wullimann, Julia Niessl, Emma B. Hodcroft, Curtis Cai, et al. (+14)
104 [GO] 2023―Mar―10 A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates Zezhong Liu, Jie Zhou, Xinling Wang, Wei Xu, Zheng Teng, Hongyou Chen, et al. (+7)
105 [GO] 2023―Mar―09 Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection Vignesh N. Hariharan, Minwook Shin, Ching-Wen Chang, Daniel O’Reilly, Annabelle Biscans, Ken Yamada, et al. (+40)
106 [GO] 2023―Mar―07 Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19 Thais G. Moreira, Christian D. Gauthier, Liam Murphy, Toby B. Lanser, Anu Paul, Kimble T. F. Matos, et al. (+8)
107 [GO] 2023―Feb―28 Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2 Jordana Muñoz-Basagoiti, Fábio Luís Lima Monteiro, Lauren R. H. Krumpe, Victoria Armario-Najera, Shilpa R. Shenoy, Daniel Perez-Zsolt, et al. (+25)
108 [GO] 2023―Feb―27 Resolving the enigma of Iquitos and Manaus: A modeling analysis of multiple COVID-19 epidemic waves in two Amazonian cities Daihai He, Lixin Lin, Yael Artzy-Randrup, Haydar Demirhan, Benjamin J. Cowling, Lewi Stone
109 [GO] 2023―Feb―27 How to avoid a local epidemic becoming a global pandemic Nils Chr. Stenseth, Rudolf Schlatte, Xiaoli Liu, Roger Pielke, Ruiyun Li, Bin Chen, et al. (+12)
110 [GO] 2023―Feb―27 Innate immune cell activation causes lung fibrosis in a humanized model of long COVID Lu Cui, Zhuoqing Fang, Cristabelle Madona De Souza, Tristan Lerbs, Yuan Guan, Irene Li, et al. (+4)
111 [GO] 2023―Feb―08 The political polarization of COVID-19 treatments among physicians and laypeople in the United States Joel M. Levin, Leigh A. Bukowski, Julia A. Minson, Jeremy M. Kahn
112 [GO] 2023―Jan―31 White-tailed deer ( Odocoileus virginianus ) may serve as a wildlife reservoir for nearly extinct SARS-CoV-2 variants of concern Leonardo C. Caserta, Mathias Martins, Salman L. Butt, Nicholas A. Hollingshead, Lina M. Covaleda, Sohel Ahmed, et al. (+3)
113 [GO] 2023―Jan―24 Correlated substitutions reveal SARS-like coronaviruses recombine frequently with a diverse set of structured gene pools Asher Preska Steinberg, Olin K. Silander, Edo Kussell
114 [GO] 2023―Jan―24 SARS-CoV-2 evolution influences GBP and IFITM sensitivity Dejan Mesner, Ann-Kathrin Reuschl, Matthew V. X. Whelan, Taylor Bronzovich, Tafhima Haider, Lucy G. Thorne, et al. (+4)
115 [GO] 2023―Jan―23 PCIF1-mediated deposition of 5′-cap N 6 ,2′- O -dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection Lingling Wang, Shaobo Wang, Lujing Wu, Wanyu Li, William Bray, Alex E. Clark, et al. (+4)
116 [GO] 2023―Jan―20 A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients Jonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, Yuya Shirai, Yuta Yamaguchi, Teruaki Murakami, et al. (+9)
117 [GO] 2023―Jan―20 Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge Dan Bi Lee, Hyojin Kim, Ju Hwan Jeong, Ui Soon Jang, Yuyeon Jang, Seokbeom Roh, et al. (+14)
118 [GO] 2023―Jan―18 Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2 Donglan Liu, Chunke Chen, Dingbin Chen, Airu Zhu, Fang Li, Zhen Zhuang, et al. (+29)
119 [GO] 2023―Jan―17 Learning from weather and climate science to prepare for a future pandemic Sebastian Schemm, Dana Grund, Reto Knutti, Heini Wernli, Martin Ackermann, Geir Evensen
120 [GO] 2023―Jan―12 Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models Maaya Morita, Aki Yoneda, Nagisa Tokunoh, Tatsumi Masaki, Keisuke Shirakura, Mayumi Kinoshita, et al. (+19)
121 [GO] 2023―Jan―09 Rebound increase in circulating dipeptidyl peptidase 4 (DPP4) enzyme activity after acute COVID-19 Gábor Firneisz
122 [GO] 2023―Jan―09 Reply to Firneisz: “Rebound increase in circulating dipeptidyl peptidase-4 (DPP4) enzyme activity after acute Covid-19” Shu-Hai Lin, Zhu Yang
123 [GO] 2023―Jan―09 Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2 Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F. Gainor, et al. (+3)
124 [GO] 2023―Jan―04 Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2 Stefan Gahbauer, Galen J. Correy, Marion Schuller, Matteo P. Ferla, Yagmur Umay Doruk, Moira Rachman, et al. (+16)
125 [GO] 2022―Dec―27 SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, Jack Chun-Chieh Hsu, Susan M. Mitchell, Joanna Pawlak, et al. (+3)
126 [GO] 2022―Nov―23 Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong Zhanwei Du, Lin Wang, Songwei Shan, Dickson Lam, Tim K. Tsang, Jingyi Xiao, et al. (+11)
127 [GO] 2022―Nov―22 Pandemic fatigue fueled political discontent during the COVID-19 pandemic Frederik Jørgensen, Alexander Bor, Magnus Storm Rasmussen, Marie Fly Lindholt, Michael Bang Petersen
128 [GO] 2022―Nov―14 Personal hardship narrows the partisan gap in COVID-19 and climate change responses Sara M. Constantino, Alicia D. Cooperman, Robert O. Keohane, Elke U. Weber
129 [GO] 2022―Nov―14 The moral filter of patriotic prejudice: How Americans view Chinese in the COVID-19 era Qian He, Yu Xie
130 [GO] 2022―Nov―10 The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade Robert F. Garry
131 [GO] 2022―Nov―07 Protective down-regulated states in the human brain: A possible lesson from COVID-19 Nicholas D. Schiff, Emery N. Brown
132 [GO] 2022―Nov―07 Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study Nathanael R. Fillmore, Raphael E. Szalat, Jennifer La, Westyn Branch-Elliman, Paul A. Monach, Vinh Nguyen, et al. (+4)
133 [GO] 2022―Nov―07 Reply to Fillmore et al.: Additional evidence of non-SARS-CoV-2 coronavirus cross-immunity Matthew D. Solomon, Lawrence Steinman, Vincent X. Liu
134 [GO] 2022―Nov―03 Selective sweeps in SARS-CoV-2 variant competition Laura Boyle, Sofia Hletko, Jenny Huang, June Lee, Gaurav Pallod, Hwai-Ray Tung, Richard Durrett
135 [GO] 2022―Nov―02 Anti-PF4 antibodies associated with disease severity in COVID-19 Qingbo Liu, Huiyi Miao, Shuai Li, Peng Zhang, Gloria F. Gerber, Dean Follmann, et al. (+13)
136 [GO] 2022―Nov―02 Reply to Garry: The origin of SARS-CoV-2 remains unresolved Neil L. Harrison, Jeffrey D. Sachs
137 [GO] 2022―Oct―24 An experimental test of the nicotinic hypothesis of COVID-19 Nicole E. Godellas, Gisela D. Cymes, Claudio Grosman
138 [GO] 2022―Oct―18 Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant Wei Zhang, Ke Shi, Qibin Geng, Gang Ye, Hideki Aihara, Fang Li
139 [GO] 2022―Oct―17 COVID-19, climate change, and the finite pool of worry in 2019 to 2021 Twitter discussions Oleg Smirnov, Pei-Hsun Hsieh
140 [GO] 2022―Oct―10 Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses Gerald T. Keusch, John H. Amuasi, Danielle E. Anderson, Peter Daszak, Isabella Eckerle, Hume Field, et al. (+8)
141 [GO] 2022―Oct―06 Correction for Xiong et al., The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
142 [GO] 2022―Oct―05 Correction to Supporting Information for Proto et al., COVID-19 and mental health of individuals with different personalities
143 [GO] 2022―Oct―04 Masks as a moral symbol: Masks reduce wearers’ deviant behavior in China during COVID-19 Jackson G. Lu, Lesley Luyang Song, Yuhuang Zheng, Laura Changlan Wang
144 [GO] 2022―Sep―29 SARS-CoV-2 furin cleavage site was not engineered Robert F. Garry
145 [GO] 2022―Sep―20 Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic Hélène E. Aschmann, Alicia R. Riley, Ruijia Chen, Yea-Hung Chen, Kirsten Bibbins-Domingo, Andrew C. Stokes, et al. (+2)
146 [GO] 2022―Sep―19 Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein Kailu Yang, Chuchu Wang, Alex J. B. Kreutzberger, Ravi Ojha, Suvi Kuivanen, Sergio Couoh-Cardel, et al. (+14)
147 [GO] 2022―Sep―16 Kids adopt different ways of coping in wake of the pandemic Amy McDermott
148 [GO] 2022―Sep―12 COVID-19 cases and deaths in the United States follow Taylor’s law for heavy-tailed distributions with infinite variance Joel E. Cohen, Richard A. Davis, Gennady Samorodnitsky
149 [GO] 2022―Sep―08 A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters Sonali Chaturvedi, Nathan Beutler, Gustavo Vasen, Michael Pablo, Xinyue Chen, Giuliana Calia, et al. (+5)
150 [GO] 2022―Sep―08 Simulating respiratory disease transmission within and between classrooms to assess pandemic management strategies at schools Akira Endo (遠藤彰), Mitsuo Uchida (内田満夫), Yang Liu (刘扬), Katherine E. Atkins, Adam J. Kucharski, Sebastian Funk, et al. (+42)
151 [GO] 2022―Sep―01 SARS-CoV-2 requires acidic pH to infect cells Alex J. B. Kreutzberger, Anwesha Sanyal, Anand Saminathan, Louis-Marie Bloyet, Spencer Stumpf, Zhuoming Liu, et al. (+15)
152 [GO] 2022―Sep―01 Lots of long COVID treatment leads, but few are proven Leah Shaffer
153 [GO] 2022―Aug―30 Correction to Supporting Information for Psychological Science Accelerator Self-Determination Theory Collaboration, A global experiment on motivating social distancing during the COVID-19 pandemic
154 [GO] 2022―Aug―30 SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis Marisa E. McGrath, Yong Xue, Carly Dillen, Lauren Oldfield, N. Assad-Garcia, Jayshree Zaveri, et al. (+5)
155 [GO] 2022―Aug―23 Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19 Marina Aznaourova, Nils Schmerer, Harshavardhan Janga, Zhenhua Zhang, Kim Pauck, Judith Bushe, et al. (+21)
156 [GO] 2022―Aug―23 Significant impacts of the COVID-19 pandemic on race/ethnic differences in US mortality José Manuel Aburto, Andrea M. Tilstra, Ginevra Floridi, Jennifer Beam Dowd
157 [GO] 2022―Aug―22 SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern Mijia Lu, Michelle Chamblee, Yuexiu Zhang, Chengjin Ye, Piyush Dravid, Jun-Gyu Park, et al. (+13)
158 [GO] 2022―Aug―16 The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2 Hualong Xiong, Hui Sun, Siling Wang, Lunzhi Yuan, Liqin Liu, Yuhe Zhu, et al. (+25)
159 [GO] 2022―Aug―15 The effectiveness of COVID-19 testing and contact tracing in a US city Xutong Wang, Zhanwei Du, Emily James, Spencer J. Fox, Michael Lachmann, Lauren Ancel Meyers, Darlene Bhavnani
160 [GO] 2022―Aug―11 Morphological, cellular, and molecular basis of brain infection in COVID-19 patients Fernanda Crunfli, Victor C. Carregari, Flavio P. Veras, Lucas S. Silva, Mateus Henrique Nogueira, André Saraiva Leão Marcelo Antunes, et al. (+82)
161 [GO] 2022―Aug―10 Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19 Marie Cariou, Léa Picard, Laurent Guéguen, Stéphanie Jacquet, Andrea Cimarelli, Oliver I. Fregoso, et al. (+3)
162 [GO] 2022―Aug―09 Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19 Magdalene Joseph, Yin Wu, Richard Dannebaum, Florian Rubelt, Iva Zlatareva, Anna Lorenc, et al. (+35)
163 [GO] 2022―Aug―09 Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients Zhu Yang, Di Wu, Shanxin Lu, Yang Qiu, Zhengyi Hua, Fancheng Tan, et al. (+7)
164 [GO] 2022―Aug―03 Trend estimation and short-term forecasting of COVID-19 cases and deaths worldwide Ekaterina Krymova, Benjamín Béjar, Dorina Thanou, Tao Sun, Elisa Manetti, Gavin Lee, et al. (+4)
165 [GO] 2022―Aug―02 COVID-19 infection induces higher trust in strangers Diego Gambetta, Davide Morisi
166 [GO] 2022―Aug―01 Data analysis of viral complementary DNA/RNA sequences for low-frequency intrahost-single nucleotide variants in COVID-19 Samarth Chandra
167 [GO] 2022―Aug―01 Preventing soft skill decay among early-career women in STEM during COVID-19: Evidence from a longitudinal intervention Julia L. Melin, Shelley J. Correll
168 [GO] 2022―Aug―01 Reply to Chandra: Severe Acute Respiratory Syndrome-Coronavirus-2 variant analysis reveals within-host selection of intra-host single nucleotide variants Laura Bashor, Roderick B. Gagne, Angela Bosco-Lauth, Richard A. Bowen, Mark Stenglein, Sue VandeWoude
169 [GO] 2022―Jul―27 Risk of severe COVID-19 infection among adults with prior exposure to children Matthew D. Solomon, Gabriel J. Escobar, Yun Lu, David Schlessinger, Jonathan B. Steinman, Lawrence Steinman, et al. (+2)
170 [GO] 2022―Jul―27 Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity Chiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, Sanae Ikehara, Kazuhiko Azuma, Tadanaga Shimada, et al. (+43)
171 [GO] 2022―Jul―27 A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike Yuexiu Zhang, Mijia Lu, K C Mahesh, Eunsoo Kim, Mohamed M. Shamseldin, Chengjin Ye, et al. (+17)
172 [GO] 2022―Jul―26 QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis Michelle N. Vu, Kumari G. Lokugamage, Jessica A. Plante, Dionna Scharton, Aaron O. Bailey, Stephanea Sotcheff, et al. (+12)
173 [GO] 2022―Jul―25 SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation Zhang Xu, Jung-Hyun Choi, David L. Dai, Jun Luo, Reese Jalal Ladak, Qian Li, et al. (+23)
174 [GO] 2022―Jul―22 Interferon resistance of emerging SARS-CoV-2 variants Kejun Guo, Bradley S. Barrett, James H. Morrison, Kaylee L. Mickens, Eszter K. Vladar, Kim J. Hasenkrug, et al. (+2)
175 [GO] 2022―Jul―19 Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles Abdullah M. Syed, Alison Ciling, Taha Y. Taha, Irene P. Chen, Mir M. Khalid, Bharath Sreekumar, et al. (+15)
176 [GO] 2022―Jul―18 In SARS-CoV-2, astrocytes are in it for the long haul Shuhan Huang, Gord Fishell
177 [GO] 2022―Jul―15 The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2 Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, Alison P. Galvani, Alex Dornburg
178 [GO] 2022―Jul―15 Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes Halina Mikolajek, Miriam Weckener, Z. Faidon Brotzakis, Jiandong Huo, Evmorfia V. Dalietou, Audrey Le Bas, et al. (+14)
179 [GO] 2022―Jul―14 Abrupt decreases in infectivity of SARS-CoV-2 in aerosols Jakob Löndahl, Malin Alsved
180 [GO] 2022―Jul―12 Transient and durable T cell reactivity after COVID-19 Anna Martner, Hanna Grauers Wiktorin, Andreas Törnell, Johan Ringlander, Mohammad Arabpour, Magnus Lindh, et al. (+3)
181 [GO] 2022―Jul―12 Tropism of SARS-CoV-2 for human cortical astrocytes Madeline G. Andrews, Tanzila Mukhtar, Ugomma C. Eze, Camille R. Simoneau, Jayden Ross, Neelroop Parikshak, et al. (+22)
182 [GO] 2022―Jul―12 The global succinylation of SARS-CoV-2-infected host cells reveals drug targets Quan Liu, Heming Wang, He Zhang, Liyan Sui, Letian Li, Wang Xu, et al. (+22)
183 [GO] 2022―Jul―12 Universal healthcare and the pandemic mortality gap David Fisman
184 [GO] 2022―Jul―11 The influence of social norms varies with “others” groups: Evidence from COVID-19 vaccination intentions Nathaniel Rabb, Jake Bowers, David Glick, Kevin H. Wilson, David Yokum
185 [GO] 2022―Jun―29 A broad and potent neutralization epitope in SARS-related coronaviruses Meng Yuan, Xueyong Zhu, Wan-ting He, Panpan Zhou, Chengzi I. Kaku, Tazio Capozzola, et al. (+15)
186 [GO] 2022―Jun―28 Mental health, financial, and social outcomes among older adults with probable COVID-19 infection: A longitudinal cohort study Eleonora Iob, Andrew Steptoe, Paola Zaninotto
187 [GO] 2022―Jun―28 Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2 Ahmed Mahas, Tin Marsic, Mauricio Lopez-Portillo Masson, Qiaochu Wang, Rashid Aman, Cheng Zheng, et al. (+6)
188 [GO] 2022―Jun―28 Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor Deependra Kumar Ban, Tyler Bodily, Abhijith G. Karkisaval, Yongliang Dong, Shreyam Natani, Anirudh Ramanathan, et al. (+5)
189 [GO] 2022―Jun―28 The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment Henry P. Oswin, Allen E. Haddrell, Mara Otero-Fernandez, Jamie F. S. Mann, Tristan A. Cogan, Thomas G. Hilditch, et al. (+6)
190 [GO] 2022―Jun―27 Assessing inequities underlying racial disparities of COVID-19 mortality in Louisiana parishes Guangxiao Hu, Nora Hamovit, Kristen Croft, Jennifer D. Roberts, Deb Niemeier
191 [GO] 2022―Jun―24 Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction Guillaume Beucher, Marie-Lise Blondot, Alexis Celle, Noémie Pied, Patricia Recordon-Pinson, Pauline Esteves, et al. (+14)
192 [GO] 2022―Jun―23 Estimates from 31 countries show the significant impact of COVID-19 excess mortality on the incidence of family bereavement Mallika Snyder, Diego Alburez-Gutierrez, Iván Williams, Emilio Zagheni
193 [GO] 2022―Jun―23 Schools under mandatory testing can mitigate the spread of SARS-CoV-2 Marc Diederichs, Reyn van Ewijk, Ingo E. Isphording, Nico Pestel
194 [GO] 2022―Jun―23 Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors Karan Kapoor, Tianle Chen, Emad Tajkhorshid
195 [GO] 2022―Jun―17 The societal responses to COVID-19: Evidence from the G7 countries Katharina Lima de Miranda, Dennis J. Snower
196 [GO] 2022―Jun―14 SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis Chao Qin, Youliang Rao, Hao Yuan, Ting-Yu Wang, Jun Zhao, Bianca Espinosa, et al. (+12)
197 [GO] 2022―Jun―13 Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic Alison P. Galvani, Alyssa S. Parpia, Abhishek Pandey, Pratha Sah, Kenneth Colón, Gerald Friedman, et al. (+4)
198 [GO] 2022―Jun―13 ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1 Boris Simonetti, James L. Daly, Lorena Simón-Gracia, Katja Klein, Saroja Weeratunga, Carlos Antón-Plágaro, et al. (+10)
199 [GO] 2022―Jun―13 Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas Alberto Aleta, David Martín-Corral, Michiel A. Bakker, Ana Pastore y Piontti, Marco Ajelli, Maria Litvinova, et al. (+8)
200 [GO] 2022―Jun―09 One lesson of COVID-19: Conduct more health policy trials Luchuo Engelbert Bain, Astrid Berner-Rodoreda, Shannon A. McMahon, Malabika Sarker, Frank Tanser, Till Bärnighausen, et al. (+2)
201 [GO] 2022―Jun―09 Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection Jeffrey L. Americo, Catherine A. Cotter, Patricia L. Earl, Ruikang Liu, Bernard Moss
202 [GO] 2022―May―31 Mask wearing in community settings reduces SARS-CoV-2 transmission Gavin Leech, Charlie Rogers-Smith, Joshua Teperowski Monrad, Jonas B. Sandbrink, Benedict Snodin, Robert Zinkov, et al. (+8)
203 [GO] 2022―May―27 A global experiment on motivating social distancing during the COVID-19 pandemic Nicole Legate, Thuy-vy Ngyuen, Netta Weinstein, Arlen Moller, Lisa Legault, Zahir Vally, et al. (+549)
204 [GO] 2022―May―24 Simulating COVID-19 classroom transmission on a university campus Arvin Hekmati, Mitul Luhar, Bhaskar Krishnamachari, Maja Matarić
205 [GO] 2022―May―20 MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells Courtney E. Comar, Clayton J. Otter, Jessica Pfannenstiel, Ethan Doerger, David M. Renner, Li Hui Tan, et al. (+4)
206 [GO] 2022―May―19 Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis Mostafa M. Eltobgy, Ashley Zani, Adam D. Kenney, Shady Estfanous, Eunsoo Kim, Asmaa Badr, et al. (+36)
207 [GO] 2022―May―19 A call for an independent inquiry into the origin of the SARS-CoV-2 virus Neil L. Harrison, Jeffrey D. Sachs
208 [GO] 2022―May―17 How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19 Ryan Baxter-King, Jacob R. Brown, Ryan D. Enos, Arash Naeim, Lynn Vavreck
209 [GO] 2022―May―17 Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection Chao Zhang, Anurag Verma, Yuanqing Feng, Marcelo C. R. Melo, Michael McQuillan, Matthew Hansen, et al. (+73)
210 [GO] 2022―May―16 The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies Jérémy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, et al. (+1161)
211 [GO] 2022―May―13 Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants Brock Kingstad-Bakke, Woojong Lee, Shaswath S. Chandrasekar, David J. Gasper, Cristhian Salas-Quinchucua, Thomas Cleven, et al. (+4)
212 [GO] 2022―May―12 Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody Jonathan L. Torres, Gabriel Ozorowski, Emanuele Andreano, Hejun Liu, Jeffrey Copps, Giulia Piccini, et al. (+17)
213 [GO] 2022―May―04 Corruption should be taken into account when considering COVID-19 vaccine allocation Armin Spreco, Thomas Schön, Toomas Timpka
214 [GO] 2022―May―04 Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations Raymond Duch, Thomas S. Robinson, Philip M. Clarke, Laurence S. J. Roope, Mara Violato
215 [GO] 2022―May―03 Determining containment policy impacts on public sentiment during the pandemic using social media data Prakash Chandra Sukhwal, Atreyi Kankanhalli
216 [GO] 2022―Apr―27 An ensemble model based on early predictors to forecast COVID-19 health care demand in France Juliette Paireau, Alessio Andronico, Nathanaël Hozé, Maylis Layan, Pascal Crépey, Alix Roumagnac, et al. (+3)
217 [GO] 2022―Apr―27 Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants Jessica Hong, Hyung Joon Kwon, Raul Cachau, Catherine Z. Chen, Kevin John Butay, Zhijian Duan, et al. (+12)
218 [GO] 2022―Apr―25 The perceived effectiveness and hidden inequity of postpandemic fiscal stimuli Yaxin Zhang, Xinzhu Zheng, Daqian Jiang, Huilin Luo, Kaidi Guo, Xinke Song, Can Wang
219 [GO] 2022―Apr―08 Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States Estee Y. Cramer, Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, et al. (+289)
220 [GO] 2022―Apr―06 COVID-19 therapeutics: Challenges and directions for the future Philip C. Robinson, David F. L. Liew, Helen L. Tanner, John R. Grainger, Raymond A. Dwek, Ronald B. Reisler, et al. (+7)
221 [GO] 2022―Apr―05 Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2 Yao Zhao, Yan Zhu, Xiang Liu, Zhenming Jin, Yinkai Duan, Qi Zhang, et al. (+13)
222 [GO] 2022―Apr―01 Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle Kailu Yang, Chuchu Wang, K. Ian White, Richard A. Pfuetzner, Luis Esquivies, Axel T. Brunger
223 [GO] 2022―Mar―30 SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13 Cameron B. Morrison, Caitlin E. Edwards, Kendall M. Shaffer, Kenza C. Araba, Jason A. Wykoff, Danielle R. Williams, et al. (+8)
224 [GO] 2022―Mar―24 An extended conformation of SARS-CoV-2 main protease reveals allosteric targets Zengchao Sun, Lu Wang, Xiyang Li, Chengpeng Fan, Jianfeng Xu, Zhenzhong Shi, et al. (+6)
225 [GO] 2022―Mar―22 Public health implications of opening National Football League stadiums during the COVID-19 pandemic Bernardo García Bulle, Dennis Shen, Devavrat Shah, Anette E. Hosoi
226 [GO] 2022―Mar―22 Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs Katrin Schmelz, Samuel Bowles
227 [GO] 2022―Mar―21 A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions Magnus S. Bauer, Sophia Gruber, Adina Hausch, Priscila S. F. C. Gomes, Lukas F. Milles, Thomas Nicolaus, et al. (+8)
228 [GO] 2022―Mar―02 Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization Sisi Shan, Shitong Luo, Ziqing Yang, Junxian Hong, Yufeng Su, Fan Ding, et al. (+9)
229 [GO] 2022―Feb―25 Specialized interferon action in COVID-19 Matthew D. Galbraith, Kohl T. Kinning, Kelly D. Sullivan, Paula Araya, Keith P. Smith, Ross E. Granrath, et al. (+18)
230 [GO] 2022―Feb―25 Lack of association between pandemic chilblains and SARS-CoV-2 infection Jeff R. Gehlhausen, Alicia J. Little, Christine J. Ko, Marc Emmenegger, Carolina Lucas, Patrick Wong, et al. (+21)
231 [GO] 2022―Feb―22 The major genetic risk factor for severe COVID-19 is associated with protection against HIV Hugo Zeberg
232 [GO] 2022―Feb―14 Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN Nicholas H. Moeller, Ke Shi, Özlem Demir, Christopher Belica, Surajit Banerjee, Lulu Yin, et al. (+3)
233 [GO] 2022―Feb―14 Correction for Yang et al., Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities
234 [GO] 2022―Feb―11 Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion Setu M. Vora, Pietro Fontana, Tianyang Mao, Valerie Leger, Ying Zhang, Tian-Min Fu, et al. (+6)
235 [GO] 2022―Feb―11 Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine Chung-Yi Wu, Cheng-Wei Cheng, Chih-Chuan Kung, Kuo-Shiang Liao, Jia-Tsrong Jan, Che Ma, Chi-Huey Wong
236 [GO] 2022―Feb―08 Self-reported COVID-19 infection and implications for mental health and food insecurity among American college students Sara Goldrick-Rab, Vanessa Coca, Japbir Gill, Morgan Peele, Kallie Clark, Elizabeth Looker
237 [GO] 2022―Feb―07 Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience Clelia Di Serio, Pietro Cippà, Alessandro Ceschi, Paolo Ferrari
238 [GO] 2022―Feb―07 Testing fractional doses of COVID-19 vaccines Witold Więcek, Amrita Ahuja, Esha Chaudhuri, Michael Kremer, Alexandre Simoes Gomes, Christopher M. Snyder, et al. (+2)
239 [GO] 2022―Feb―07 Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection Jonas Schuhenn, Toni Luise Meister, Daniel Todt, Thilo Bracht, Karin Schork, Jean-Noel Billaud, et al. (+26)
240 [GO] 2022―Feb―01 Real-time pandemic surveillance using hospital admissions and mobility data Spencer J. Fox, Michael Lachmann, Mauricio Tec, Remy Pasco, Spencer Woody, Zhanwei Du, et al. (+10)
241 [GO] 2022―Jan―26 Encouraging the resumption of economic activity after COVID-19: Evidence from a large scale-field experiment in China Juan Palacios, Yichun Fan, Erez Yoeli, Jianghao Wang, Yuchen Chai, Weizeng Sun, et al. (+2)
242 [GO] 2022―Jan―25 Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells Razie Amraei, Chaoshuang Xia, Judith Olejnik, Mitchell R. White, Marc A. Napoleon, Saran Lotfollahzadeh, et al. (+6)
243 [GO] 2022―Jan―25 Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer Suresh V. Kuchipudi, Meera Surendran-Nair, Rachel M. Ruden, Michele Yon, Ruth H. Nissly, Kurt J. Vandegrift, et al. (+12)
244 [GO] 2022―Jan―24 Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein Yunlong Shi, Ari Zeida, Caitlin E. Edwards, Michael L. Mallory, Santiago Sastre, Matías R. Machado, et al. (+8)
245 [GO] 2022―Jan―21 Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2 Johan Ringlander, Joshua Fingal, Hanna Kann, Kasthuri Prakash, Gustaf Rydell, Maria Andersson, et al. (+5)
246 [GO] 2022―Jan―20 Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants Hannah W. Despres, Margaret G. Mills, David J. Shirley, Madaline M. Schmidt, Meei-Li Huang, Pavitra Roychoudhury, et al. (+3)
247 [GO] 2022―Jan―19 COVID-19 increased censorship circumvention and access to sensitive topics in China Keng-Chi Chang, William R. Hobbs, Margaret E. Roberts, Zachary C. Steinert-Threlkeld
248 [GO] 2022―Jan―18 Politicians polarize and experts depolarize public support for COVID-19 management policies across countries Alexandra Flores, Jennifer C. Cole, Stephan Dickert, Kimin Eom, Gabriela M. Jiga-Boy, Tehila Kogut, et al. (+9)
249 [GO] 2022―Jan―14 Targeted vaccination and the speed of SARS-CoV-2 adaptation Sylvain Gandon, Sébastien Lion
250 [GO] 2022―Jan―12 SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry Bo Yang, Yuanyuan Jia, Yumin Meng, Ying Xue, Kefang Liu, Yan Li, et al. (+19)
251 [GO] 2022―Jan―12 Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes Juan Rodriguez-Rivas, Giancarlo Croce, Maureen Muscat, Martin Weigt
252 [GO] 2022―Jan―10 Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave Nathaniel Hupert, Daniela Marín-Hernández, Bo Gao, Ricardo Águas, Douglas F. Nixon
253 [GO] 2021―Dec―30 Modeling for COVID-19 college reopening decisions: Cornell, a case study Peter I. Frazier, J. Massey Cashore, Ning Duan, Shane G. Henderson, Alyf Janmohamed, Brian Liu, et al. (+3)
254 [GO] 2021―Dec―30 A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface Juliette Leon, Daniel A. Michelson, Judith Olejnik, Kaitavjeet Chowdhary, Hyung Suk Oh, Adam J. Hume, et al. (+10)
255 [GO] 2021―Dec―22 SARS-CoV-2 spreads through cell-to-cell transmission Cong Zeng, John P. Evans, Tiffany King, Yi-Min Zheng, Eugene M. Oltz, Sean P. J. Whelan, et al. (+3)
256 [GO] 2021―Dec―20 SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation Shi Yu, Xu Zheng, Bingjie Zhou, Juan Li, Mengdan Chen, Rong Deng, et al. (+3)
257 [GO] 2021―Dec―13 Can auxiliary indicators improve COVID-19 forecasting and hotspot prediction? Daniel J. McDonald, Jacob Bien, Alden Green, Addison J. Hu, Nat DeFries, Sangwon Hyun, et al. (+7)
258 [GO] 2021―Dec―13 An open repository of real-time COVID-19 indicators Alex Reinhart, Logan Brooks, Maria Jahja, Aaron Rumack, Jingjing Tang, Sumit Agrawal, et al. (+61)
259 [GO] 2021―Dec―13 Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base Christina M. Astley, Gaurav Tuli, Kimberly A. Mc Cord, Emily L. Cohn, Benjamin Rader, Tanner J. Varrelman, et al. (+9)
260 [GO] 2021―Dec―13 The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination Joshua A. Salomon, Alex Reinhart, Alyssa Bilinski, Eu Jing Chua, Wichada La Motte-Kerr, Minttu M. Rönn, et al. (+7)
261 [GO] 2021―Dec―13 SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes Paulina Pawlica, Therese A. Yario, Sylvia White, Jianhui Wang, Walter N. Moss, Pei Hui, et al. (+2)
262 [GO] 2021―Dec―09 LinearTurboFold: Linear-time global prediction of conserved structures for RNA homologs with applications to SARS-CoV-2 Sizhen Li, He Zhang, Liang Zhang, Kaibo Liu, Boxiang Liu, David H. Mathews, Liang Huang
263 [GO] 2021―Dec―07 Computing the daily reproduction number of COVID-19 by inverting the renewal equation using a variational technique Luis Alvarez, Miguel Colom, Jean-David Morel, Jean-Michel Morel
264 [GO] 2021―Dec―07 A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry Julián Valero, Laia Civit, Daniel M. Dupont, Denis Selnihhin, Line S. Reinert, Manja Idorn, et al. (+10)
265 [GO] 2021―Dec―07 A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters Xueqiao Liu, Cindy Luongo, Yumiko Matsuoka, Hong-Su Park, Celia Santos, Lijuan Yang, et al. (+12)
266 [GO] 2021―Dec―06 How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology Naomi R. Waterlow, Edwin van Leeuwen, Nicholas G. Davies, Stefan Flasche, Rosalind M. Eggo
267 [GO] 2021―Dec―06 Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells Jian Chen, Jun Fan, Zhilu Chen, Miaomiao Zhang, Haoran Peng, Jian Liu, et al. (+7)
268 [GO] 2021―Dec―02 In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness Ruian Ke, Carolin Zitzmann, David D. Ho, Ruy M. Ribeiro, Alan S. Perelson
269 [GO] 2021―Nov―29 Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021 Scott E. Bokemper, Alan S. Gerber, Saad B. Omer, Gregory A. Huber
270 [GO] 2021―Nov―17 Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage Marcus A. Banks
271 [GO] 2021―Nov―15 Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein Linhua Tai, Guoliang Zhu, Minnan Yang, Lei Cao, Xiaorui Xing, Guoliang Yin, et al. (+6)
272 [GO] 2021―Nov―12 Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic Núria López, Luigi Del Debbio, Marc Baaden, Matej Praprotnik, Laura Grigori, Catarina Simões, et al. (+12)
273 [GO] 2021―Nov―09 Societal shifts due to COVID-19 reveal large-scale complexities and feedbacks between atmospheric chemistry and climate change Joshua L. Laughner, Jessica L. Neu, David Schimel, Paul O. Wennberg, Kelley Barsanti, Kevin W. Bowman, et al. (+33)
274 [GO] 2021―Nov―08 Plastic waste release caused by COVID-19 and its fate in the global ocean Yiming Peng, Peipei Wu, Amina T. Schartup, Yanxu Zhang
275 [GO] 2021―Nov―08 COVID-19 within families amplifies the prosociality gap between adolescents of high and low socioeconomic status Camille Terrier, Daniel L. Chen, Matthias Sutter
276 [GO] 2021―Nov―03 SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus) Jeffrey C. Chandler, Sarah N. Bevins, Jeremy W. Ellis, Timothy J. Linder, Rachel M. Tell, Melinda Jenkins-Moore, et al. (+7)
277 [GO] 2021―Nov―03 Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation Liping Zhang, Matthew Mann, Zulfeqhar A. Syed, Hayley M. Reynolds, E. Tian, Nadine L. Samara, et al. (+3)
278 [GO] 2021―Nov―02 SARS-CoV-2 indoor air transmission is a threat that can be addressed with science Jonathan M. Samet, Thomas A. Burke, Seema S. Lakdawala, John J. Lowe, Linsey C. Marr, Kimberly A. Prather, et al. (+2)
279 [GO] 2021―Nov―01 Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs Ke Pan, Yulun Chiu, Eric Huang, Michelle Chen, Junmei Wang, Ivy Lai, et al. (+4)
280 [GO] 2021―Oct―29 SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection Laura Bashor, Roderick B. Gagne, Angela M. Bosco-Lauth, Richard A. Bowen, Mark Stenglein, Sue VandeWoude
281 [GO] 2021―Oct―26 Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing Erica Briggs, William Ward, Sol Rey, Dylan Law, Katharine Nelson, Michael Bois, et al. (+4)
282 [GO] 2021―Oct―26 Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG Lin Sun, Somanath Kallolimath, Roman Palt, Karin Stiasny, Patrick Mayrhofer, Daniel Maresch, et al. (+2)
283 [GO] 2021―Oct―26 Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child Romain Lévy, Peng Zhang, Paul Bastard, Karim Dorgham, Isabelle Melki, Alice Hadchouel, et al. (+16)
284 [GO] 2021―Oct―26 Reply to Briggs et al.: Genomic integration and expression of SARS-CoV-2 sequences can explain prolonged or recurrent viral RNA detection Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, Rudolf Jaenisch
285 [GO] 2021―Oct―26 An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination Dengning Xia, Rui Jin, Gaurav Byagathvalli, Huan Yu, Ling Ye, Chao-Yi Lu, et al. (+3)
286 [GO] 2021―Oct―20 Opinion: The importance of offering vaccine choice in the fight against COVID-19 Mark T. Hughes, Paul G. Auwaerter, Michael R. Ehmann, Brian T. Garibaldi, Sherita H. Golden, Ting-Jia Lorigiano, et al. (+3)
287 [GO] 2021―Oct―19 COVID-19 lockdowns drive decline in active fires in southeastern United States Benjamin Poulter, Patrick H. Freeborn, W. Matt Jolly, J. Morgan Varner
288 [GO] 2021―Oct―15 A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants Novalia Pishesha, Thibault J. Harmand, Paul W. Rothlauf, Patrique Praest, Ryan K. Alexander, Renate van den Doel, et al. (+15)
289 [GO] 2021―Oct―12 The association of opening K-12 schools with the spread of COVID-19 in the United States: County-level panel data analysis Victor Chernozhukov, Hiroyuki Kasahara, Paul Schrimpf
290 [GO] 2021―Oct―11 A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, Dong hee Chung, André Luiz Lourenço, Dustin Pwee, et al. (+17)
291 [GO] 2021―Oct―08 COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions Emiko Urano, Tomotaka Okamura, Chikako Ono, Shiori Ueno, Satoshi Nagata, Haruhiko Kamada, et al. (+6)
292 [GO] 2021―Oct―08 A discrete-time infectious disease model for global pandemics Abdul-Aziz Yakubu
293 [GO] 2021―Oct―06 Distant residues modulate conformational opening in SARS-CoV-2 spike protein Dhiman Ray, Ly Le, Ioan Andricioaei
294 [GO] 2021―Oct―01 The impact of social isolation and changes in work patterns on ongoing thought during the first COVID-19 lockdown in the United Kingdom Brontë Mckeown, Giulia L. Poerio, Will H. Strawson, Léa M. Martinon, Leigh M. Riby, Elizabeth Jefferies, et al. (+2)
295 [GO] 2021―Oct―01 Highly active engineered IgG3 antibodies against SARS-CoV-2 Somanath Kallolimath, Lin Sun, Roman Palt, Karin Stiasny, Patrick Mayrhofer, Clemens Gruber, et al. (+3)
296 [GO] 2021―Sep―30 Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition Xiaolei Liu, Anurag Verma, Gustavo Garcia, Holly Ramage, Anastasia Lucas, Rebecca L. Myers, et al. (+13)
297 [GO] 2021―Sep―29 Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2 Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, Ratul Chowdhury, Victoria S. Cavener, Ruth H. Nissly, et al. (+6)
298 [GO] 2021―Sep―29 Correction for Ristaino et al., The persistent threat of emerging plant disease pandemics to global food security
299 [GO] 2021―Sep―28 Model-driven mitigation measures for reopening schools during the COVID-19 pandemic Ryan Seamus McGee, Julian R. Homburger, Hannah E. Williams, Carl T. Bergstrom, Alicia Y. Zhou
300 [GO] 2021―Sep―27 Learning from near misses from COVID-19 Chander Velu, Sriya Iyer
301 [GO] 2021―Sep―27 Reply to Velu and Iyer: The promise and limits of “near-miss” pandemic-related research Tim Johnson, Dalton Conley
302 [GO] 2021―Sep―27 Trust in scientists in times of pandemic: Panel evidence from 12 countries Yann Algan, Daniel Cohen, Eva Davoine, Martial Foucault, Stefanie Stantcheva
303 [GO] 2021―Sep―24 Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses Chengjin Ye, Kevin Chiem, Jun-Gyu Park, Jesus A. Silvas, Desarey Morales Vasquez, Julien Sourimant, et al. (+8)
304 [GO] 2021―Sep―21 High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19 Magda Lourda, Majda Dzidic, Laura Hertwig, Helena Bergsten, Laura M. Palma Medina, Indranil Sinha, et al. (+31)
305 [GO] 2021―Sep―20 How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective Emanuel Goldman
306 [GO] 2021―Sep―17 Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice Neil C. Dalvie, Sergio A. Rodriguez-Aponte, Brittany L. Hartwell, Lisa H. Tostanoski, Andrew M. Biedermann, Laura E. Crowell, et al. (+38)
307 [GO] 2021―Sep―15 Deep learning identifies synergistic drug combinations for treating COVID-19 Wengong Jin, Jonathan M. Stokes, Richard T. Eastman, Zina Itkin, Alexey V. Zakharov, James J. Collins, et al. (+2)
308 [GO] 2021―Sep―15 Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities Raymond Duch, Laurence S. J. Roope, Mara Violato, Matias Fuentes Becerra, Thomas S. Robinson, Jean-Francois Bonnefon, et al. (+12)
309 [GO] 2021―Sep―15 Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2 William J. Melvin, Christopher O. Audu, Frank M. Davis, Sriganesh B. Sharma, Amrita Joshi, Aaron DenDekker, et al. (+10)
310 [GO] 2021―Sep―15 Asymptomatic infection is the pandemic’s dark matter David N. Fisman, Ashleigh R. Tuite
311 [GO] 2021―Sep―14 COVID-19 and mental health of individuals with different personalities Eugenio Proto, Anwen Zhang
312 [GO] 2021―Sep―14 A simple model for control of COVID-19 infections on an urban campus Robert A. Brown
313 [GO] 2021―Sep―14 Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease Mira A. M. Behnam, Christian D. Klein
314 [GO] 2021―Sep―14 Reply to Behnam and Klein: Potential role of the His-tag in C-terminal His-tagged SARS-CoV-2 main protease Zhe Li, Runduo Liu, Chang-Guo Zhan, Xin Wang, Hai-Bin Luo
315 [GO] 2021―Sep―01 Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques Hannah A. D. King, M. Gordon Joyce, Ines Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra, et al. (+51)
316 [GO] 2021―Aug―30 Early assessment of the relationship between the COVID-19 pandemic and births in high-income countries Arnstein Aassve, Nicolò Cavalli, Letizia Mencarini, Samuel Plach, Seth Sanders
317 [GO] 2021―Aug―30 Priming COVID-19 salience increases prejudice and discriminatory intent against Asians and Hispanics Yao Lu, Neeraj Kaushal, Xiaoning Huang, S. Michael Gaddis
318 [GO] 2021―Aug―27 Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1 Shilei Zhang, Jingfeng Wang, Genhong Cheng
319 [GO] 2021―Aug―26 The COVID-19 pandemic adds another 200,000 deaths (50%) to the annual toll of excess mortality in the United States Patrick Heuveline
320 [GO] 2021―Aug―25 Profound Treg perturbations correlate with COVID-19 severity Silvia Galván-Peña, Juliette Leon, Kaitavjeet Chowdhary, Daniel A. Michelson, Brinda Vijaykumar, Liang Yang, et al. (+12)
321 [GO] 2021―Aug―23 Using time-use diaries to track changing behavior across successive stages of COVID-19 social restrictions Oriel Sullivan, Jonathan Gershuny, Almudena Sevilla, Francesca Foliano, Margarita Vega-Rapun, Juana Lamote de Grignon, et al. (+2)
322 [GO] 2021―Aug―23 Correction for Benton et al., The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
323 [GO] 2021―Aug―23 DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors Srinivas Chamakuri, Shuo Lu, Melek Nihan Ucisik, Kurt M. Bohren, Ying-Chu Chen, Huang-Chi Du, et al. (+17)
324 [GO] 2021―Aug―20 SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma Emanuele Andreano, Giulia Piccini, Danilo Licastro, Lorenzo Casalino, Nicole V. Johnson, Ida Paciello, et al. (+12)
325 [GO] 2021―Aug―19 Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19 Carmen Mirabelli, Jesse W. Wotring, Charles J. Zhang, Sean M. McCarty, Reid Fursmidt, Carla D. Pretto, et al. (+17)
326 [GO] 2021―Aug―19 Incentives can spur COVID-19 vaccination uptake Heike Klüver, Felix Hartmann, Macartan Humphreys, Ferdinand Geissler, Johannes Giesecke
327 [GO] 2021―Aug―18 Electricity consumption of Singaporean households reveals proactive community response to COVID-19 progression Gururaghav Raman, Jimmy Chih-Hsien Peng
328 [GO] 2021―Aug―18 Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions Paulo J. S. Silva, Claudia Sagastizábal, Luís Gustavo Nonato, Claudio José Struchiner, Tiago Pereira
329 [GO] 2021―Aug―16 Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome Bindu D. Paul, Marian D. Lemle, Anthony L. Komaroff, Solomon H. Snyder
330 [GO] 2021―Aug―16 The human factor between airborne pollen concentrations and COVID-19 disease dynamics Cornelia Betsch, Philipp Sprengholz
331 [GO] 2021―Aug―16 Reply to Betsch and Sprengholz: Higher SARS-CoV-2 infection numbers related to more airborne pollen, regardless of testing frequency Stefanie Gilles, Claudia Traidl-Hoffmann, Athanasios Damialis
332 [GO] 2021―Aug―16 Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription-free exponential amplification reaction, RTF-EXPAR Jake G. Carter, Lorea Orueta Iturbe, Jean-Louis H. A. Duprey, Ian R. Carter, Craig D. Southern, Marium Rana, et al. (+6)
333 [GO] 2021―Aug―11 Predicting the effect of confinement on the COVID-19 spread using machine learning enriched with satellite air pollution observations Xiaofan Xing, Yuankang Xiong, Ruipu Yang, Rong Wang, Weibing Wang, Haidong Kan, et al. (+20)
334 [GO] 2021―Aug―10 Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis Pratha Sah, Meagan C. Fitzpatrick, Charlotte F. Zimmer, Elaheh Abdollahi, Lyndon Juden-Kelly, Seyed M. Moghadas, et al. (+2)
335 [GO] 2021―Aug―09 Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2 Moriya Slavin, Joanna Zamel, Keren Zohar, Tsiona Eliyahu, Merav Braitbard, Esther Brielle, et al. (+8)
336 [GO] 2021―Aug―06 Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2 Cornelia Betsch, Philipp Sprengholz, Regina Siegers, Sarah Eitze, Lars Korn, Laura Goldhahn, et al. (+4)
337 [GO] 2021―Aug―03 No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues Rhys Parry, Robert J. Gifford, Spyros Lytras, Stuart C. Ray, Lachlan J. M. Coin
338 [GO] 2021―Aug―03 Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, Rudolf Jaenisch
339 [GO] 2021―Aug―02 Pairing facts with imagined consequences improves pandemic-related risk perception Alyssa H. Sinclair, Shabnam Hakimi, Matthew L. Stanley, R. Alison Adcock, Gregory R. Samanez-Larkin
340 [GO] 2021―Jul―29 Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination Ritu Agarwal, Michelle Dugas, Jui Ramaprasad, Junjie Luo, Gujie Li, Guodong (Gordon) Gao
341 [GO] 2021―Jul―28 Building toward useful SARS-CoV-2 models in Africa Belinda Archibong, C. Jessica E. Metcalf
342 [GO] 2021―Jul―27 Emphasize personal health benefits to boost COVID-19 vaccination rates Madison Ashworth, Linda Thunström, Todd L. Cherry, Stephen C. Newbold, David C. Finnoff
343 [GO] 2021―Jul―26 Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys Nicholas J. Irons, Adrian E. Raftery
344 [GO] 2021―Jul―20 Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries Xiaoyi Han, Yilan Xu, Linlin Fan, Yi Huang, Minhong Xu, Song Gao
345 [GO] 2021―Jul―20 COVID-19 pandemic reveals persistent disparities in nitrogen dioxide pollution Gaige Hunter Kerr, Daniel L. Goldberg, Susan C. Anenberg
346 [GO] 2021―Jul―14 Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones Sten Rüdiger, Stefan Konigorski, Alexander Rakowski, Jonathan Antonio Edelman, Detlef Zernick, Alexander Thieme, Christoph Lippert
347 [GO] 2021―Jul―12 Awareness and use of (emergency) sick leave: US employees’ unaddressed sick leave needs in a global pandemic Emma Jelliffe, Paul Pangburn, Stefan Pichler, Nicolas R. Ziebarth
348 [GO] 2021―Jul―09 Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes Lucas F. de Lima, André L. Ferreira, Marcelo D. T. Torres, William R. de Araujo, Cesar de la Fuente-Nunez
349 [GO] 2021―Jul―07 Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay Woo Dae Jang, Sangeun Jeon, Seungtaek Kim, Sang Yup Lee
350 [GO] 2021―Jul―07 Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain Daniela I. Staquicini, Fenny H. F. Tang, Christopher Markosian, Virginia J. Yao, Fernanda I. Staquicini, Esteban Dodero-Rojas, et al. (+15)
351 [GO] 2021―Jul―06 Reply to Dushoff et al. and Pifarré i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life Joshua R. Goldstein, Thomas Cassidy, Kenneth W. Wachter
352 [GO] 2021―Jul―06 Transmission dynamics are crucial to COVID-19 vaccination policy Jonathan Dushoff, Caroline Colijn, David J. D. Earn, Benjamin M. Bolker
353 [GO] 2021―Jul―02 Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust Michael Bang Petersen, Alexander Bor, Frederik Jørgensen, Marie Fly Lindholt
354 [GO] 2021―Jul―02 Ongoing global and regional adaptive evolution of SARS-CoV-2 Nash D. Rochman, Yuri I. Wolf, Guilhem Faure, Pascal Mutz, Feng Zhang, Eugene V. Koonin
355 [GO] 2021―Jul―02 Inhalable nanocatchers for SARS-CoV-2 inhibition Han Zhang, Wenjun Zhu, Qiutong Jin, Feng Pan, Jiafei Zhu, Yanbin Liu, et al. (+5)
356 [GO] 2021―Jul―01 Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection Chamandi S. Dampalla, Jian Zheng, Krishani Dinali Perera, Lok-Yin Roy Wong, David K. Meyerholz, Harry Nhat Nguyen, et al. (+7)
357 [GO] 2021―Jun―30 Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy Ying Wang, Chen Yang, Yutong Song, J. Robert Coleman, Marcin Stawowczyk, Juliana Tafrova, et al. (+8)
358 [GO] 2021―Jun―29 Pan-African evolution of within- and between-country COVID-19 dynamics Paddy Ssentongo, Claudio Fronterre, Andrew Geronimo, Steven J. Greybush, Pamela K. Mbabazi, Joseph Muvawala, et al. (+13)
359 [GO] 2021―Jun―29 Does exhaled aerosol increase with COVID-19 infection correlate with body mass index-years? Jürgen Stohner
360 [GO] 2021―Jun―28 Correction for Edwards et al., Exhaled aerosol increases with COVID-19 infection, age, and obesity
361 [GO] 2021―Jun―25 Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests David Kline, Zehang Li, Yue Chu, Jon Wakefield, William C. Miller, Abigail Norris Turner, Samuel J. Clark
362 [GO] 2021―Jun―23 Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, Alexandra Kupke, Georgia Kalodimou, Leonard Limpinsel, et al. (+23)
363 [GO] 2021―Jun―23 Monitoring the COVID-19 epidemic with nationwide telecommunication data Joel Persson, Jurriaan F. Parie, Stefan Feuerriegel
364 [GO] 2021―Jun―21 From COVID-19 to future electrification: Assessing traffic impacts on air quality by a machine-learning model Jiani Yang, Yifan Wen, Yuan Wang, Shaojun Zhang, Joseph P. Pinto, Elyse A. Pennington, et al. (+7)
365 [GO] 2021―Jun―17 Lessons from a local effort to screen for SARS-CoV-2 Noah J. Silverstein, Jeremy Luban
366 [GO] 2021―Jun―17 Characterization of a new SARS-CoV-2 variant that emerged in Brazil Masaki Imai, Peter J. Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Shiho Chiba, Tokiko Watanabe, et al. (+53)
367 [GO] 2021―Jun―17 The potential stickiness of pandemic-induced behavior changes in the United States Deborah Salon, Matthew Wigginton Conway, Denise Capasso da Silva, Rishabh Singh Chauhan, Sybil Derrible, Abolfazl (Kouros) Mohammadian, et al. (+6)
368 [GO] 2021―Jun―14 AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2 Sheng Ye, Guozhen Zhang, Jun Jiang
369 [GO] 2021―Jun―14 Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting Yu Sun, Laura Abriola, Rachel O. Niederer, Savannah F. Pedersen, Mia M. Alfajaro, Valter Silva Monteiro, et al. (+6)
370 [GO] 2021―Jun―09 Opinion: How to ensure regulations don’t stymie much-needed COVID-19 point-of-care testing Clare Rock, Jonathan Zenilman
371 [GO] 2021―Jun―08 Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions Thomas P. Smith, Seth Flaxman, Amanda S. Gallinat, Sylvia P. Kinosian, Michael Stemkovski, H. Juliette T. Unwin, et al. (+6)
372 [GO] 2021―Jun―07 Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out Katrin Schmelz, Samuel Bowles
373 [GO] 2021―Jun―07 Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence Lok-Yin Roy Wong, Jian Zheng, Alan Sariol, Shea Lowery, David K. Meyerholz, Tom Gallagher, Stanley Perlman
374 [GO] 2021―Jun―07 Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential Ziqi Zhou, Kenrie P. Y. Hui, Ray T. Y. So, Huibin Lv, Ranawaka A. P. M. Perera, Daniel K. W. Chu, et al. (+22)
375 [GO] 2021―Jun―04 Altered amino acid profile in patients with SARS-CoV-2 infection Chris A. Rees, Christina A. Rostad, Grace Mantus, Evan J. Anderson, Ann Chahroudi, Preeti Jaggi, et al. (+11)
376 [GO] 2021―Jun―03 The total number and mass of SARS-CoV-2 virions Ron Sender, Yinon M. Bar-On, Shmuel Gleizer, Biana Bernshtein, Avi Flamholz, Rob Phillips, Ron Milo
377 [GO] 2021―May―28 Intracounty modeling of COVID-19 infection with human mobility: Assessing spatial heterogeneity with business traffic, age, and race Xiao Hou, Song Gao, Qin Li, Yuhao Kang, Nan Chen, Kaiping Chen, et al. (+3)
378 [GO] 2021―May―27 Worldviews, trust, and risk perceptions shape public acceptance of COVID-19 public health measures Michael Siegrist, Angela Bearth
379 [GO] 2021―May―27 Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein Jack Chun-Chieh Hsu, Maudry Laurent-Rolle, Joanna B. Pawlak, Craig B. Wilen, Peter Cresswell
380 [GO] 2021―May―21 The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι Yiwen Zhang, Yingshi Chen, Yuzhuang Li, Feng Huang, Baohong Luo, Yaochang Yuan, et al. (+18)
381 [GO] 2021―May―21 The persistent threat of emerging plant disease pandemics to global food security Jean B. Ristaino, Pamela K. Anderson, Daniel P. Bebber, Kate A. Brauman, Nik J. Cunniffe, Nina V. Fedoroff, et al. (+11)
382 [GO] 2021―May―20 Collectivism predicts mask use during COVID-19 Jackson G. Lu, Peter Jin, Alexander S. English
383 [GO] 2021―May―20 Analyzing the vast coronavirus literature with CoronaCentral Jake Lever, Russ B. Altman
384 [GO] 2021―May―18 Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics Konstantin Chumakov, Michael S. Avidan, Christine S. Benn, Stefano M. Bertozzi, Lawrence Blatt, Angela Y. Chang, et al. (+6)
385 [GO] 2021―May―13 Policy and weather influences on mobility during the early US COVID-19 pandemic Yihan Wu, Todd A. Mooring, Marianna Linz
386 [GO] 2021―May―11 RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection Elisa Gremese, Stefano Alivernini, Gianfranco Ferraccioli
387 [GO] 2021―May―10 Carceral-community epidemiology, structural racism, and COVID-19 disparities Eric Reinhart, Daniel L. Chen
388 [GO] 2021―May―10 Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling Sujin Kang, Toshio Tanaka, Hitomi Inoue, Chikako Ono, Shoji Hashimoto, Yoshiyuki Kioi, et al. (+7)
389 [GO] 2021―May―10 COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases Liang Cheng, Zijun Zhu, Chao Wang, Ping Wang, Yongqun Oliver He, Xue Zhang
390 [GO] 2021―May―10 2′-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography Mateusz Wilamowski, Darren A. Sherrell, George Minasov, Youngchang Kim, Ludmilla Shuvalova, Alex Lavens, et al. (+9)
391 [GO] 2021―May―10 Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities Qing Yang, Tassa K. Saldi, Patrick K. Gonzales, Erika Lasda, Carolyn J. Decker, Kimngan L. Tat, et al. (+19)
392 [GO] 2021―May―06 A kernel-modulated SIR model for Covid-19 contagious spread from county to continent Xiaolong Geng, Gabriel G. Katul, Firas Gerges, Elie Bou-Zeid, Hani Nassif, Michel C. Bo﫞l
393 [GO] 2021―May―06 Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, Rudolf Jaenisch
394 [GO] 2021―May―04 Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay Alexandra Stambaugh, Joshua W. Parks, Matthew A. Stott, Gopikrishnan G. Meena, Aaron R. Hawkins, Holger Schmidt
395 [GO] 2021―Apr―27 Network medicine framework for identifying drug-repurposing opportunities for COVID-19 Deisy Morselli Gysi, Ítalo do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, et al. (+5)
396 [GO] 2021―Apr―26 COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin Edward Bair, Timbo Stillinger, Karl Rittger, McKenzie Skiles
397 [GO] 2021―Apr―26 Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike Ahmad Reza Mehdipour, Gerhard Hummer
398 [GO] 2021―Apr―23 Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients Xiaoyue Ni, Wei Ouyang, Hyoyoung Jeong, Jin-Tae Kim, Andreas Tzaveils, Ali Mirzazadeh, et al. (+21)
399 [GO] 2021―Apr―23 Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice Phillip Pymm, Amy Adair, Li-Jin Chan, James P. Cooney, Francesca L. Mordant, Cody C. Allison, et al. (+23)
400 [GO] 2021―Apr―15 A guideline to limit indoor airborne transmission of COVID-19 Martin Z. Bazant, John W. M. Bush
401 [GO] 2021―Apr―15 Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model Denicar Lina Nascimento Fabris Maeda, Debin Tian, Hanna Yu, Nakul Dar, Vignesh Rajasekaran, Sarah Meng, et al. (+8)
402 [GO] 2021―Apr―15 Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting Kaitlin Sawatzki, Nichola J. Hill, Wendy B. Puryear, Alexa D. Foss, Jonathon J. Stone, Jonathan A. Runstadler
403 [GO] 2021―Apr―13 Understanding why we do what we do during a global pandemic Sandro Galea
404 [GO] 2021―Apr―08 Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity Alexei V. Tkachenko, Sergei Maslov, Ahmed Elbanna, George N. Wong, Zachary J. Weiner, Nigel Goldenfeld
405 [GO] 2021―Apr―07 Learning loss due to school closures during the COVID-19 pandemic Per Engzell, Arun Frey, Mark D. Verhagen
406 [GO] 2021―Apr―07 ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection Elijah L. Mena, Callie J. Donahue, Laura Pontano Vaites, Jie Li, Gergely Rona, Colin O’Leary, et al. (+10)
407 [GO] 2021―Apr―05 Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic Youpei Yan, Amyn A. Malik, Jude Bayham, Eli P. Fenichel, Chandra Couzens, Saad B. Omer
408 [GO] 2021―Apr―02 Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers Jack H. Buckner, Gerardo Chowell, Michael R. Springborn
409 [GO] 2021―Apr―02 SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes Yize Li, David M. Renner, Courtney E. Comar, Jillian N. Whelan, Hanako M. Reyes, Fabian Leonardo Cardenas-Diaz, et al. (+14)
410 [GO] 2021―Mar―29 Provisional COVID-19 infrastructure induces large, rapid increases in cycling Sebastian Kraus, Nicolas Koch
411 [GO] 2021―Mar―25 Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic Christopher R. Berry, Anthony Fowler, Tamara Glazer, Samantha Handel-Meyer, Alec MacMillen
412 [GO] 2021―Mar―25 Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing Xi He, Shuo Quan, Min Xu, Silveria Rodriguez, Shih Lin Goh, Jiajie Wei, et al. (+8)
413 [GO] 2021―Mar―24 Opinion: Past is future for the era of COVID-19 research in the social sciences Dalton Conley, Tim Johnson
414 [GO] 2021―Mar―24 Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet) Lars Korn, Robert Böhm, Cornelia Betsch
415 [GO] 2021―Mar―22 Vaccination as a social contract: The case of COVID-19 and US political partisanship Ori Weisel
416 [GO] 2021―Mar―19 Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control Kim Sneppen, Bjarke Frost Nielsen, Robert J. Taylor, Lone Simonsen
417 [GO] 2021―Mar―17 Prioritizing COVID-19 vaccination by age Marcia C. Castro, Burton Singer
418 [GO] 2021―Mar―16 Exposure density and neighborhood disparities in COVID-19 infection risk Boyeong Hong, Bartosz J. Bonczak, Arpit Gupta, Lorna E. Thorpe, Constantine E. Kontokosta
419 [GO] 2021―Mar―11 Pandemic response policies’ democratizing effects on online learning Rene F. Kizilcec, Christos A. Makridis, Katharine C. Sadowski
420 [GO] 2021―Mar―09 A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike Mijia Lu, Piyush Dravid, Yuexiu Zhang, Sheetal Trivedi, Anzhong Li, Olivia Harder, et al. (+20)
421 [GO] 2021―Mar―09 One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection Ruikang Liu, Jeffrey L. Americo, Catherine A. Cotter, Patricia L. Earl, Noam Erez, Chen Peng, Bernard Moss
422 [GO] 2021―Mar―08 A multicountry perspective on gender differences in time use during COVID-19 Laura M. Giurge, Ashley V. Whillans, Ayse Yemiscigil
423 [GO] 2021―Mar―08 Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe Athanasios Damialis, Stefanie Gilles, Mikhail Sofiev, Viktoria Sofieva, Franziska Kolek, Daniela Bayr, et al. (+8)
424 [GO] 2021―Mar―08 Correction for Finlay et al., The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome
425 [GO] 2021―Mar―08 Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses Joseph A. Kendra, Kentaro Tohma, Lauren A. Ford-Siltz, Cara J. Lepore, Gabriel I. Parra
426 [GO] 2021―Mar―05 Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation David-A. Mendels, Laurent Dortet, Cécile Emeraud, Saoussen Oueslati, Delphine Girlich, Jean-Baptiste Ronat, et al. (+4)
427 [GO] 2021―Mar―03 Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States Surya Singh, Mujaheed Shaikh, Katharina Hauck, Marisa Miraldo
428 [GO] 2021―Mar―03 Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 Yinghui Liu, Gaowei Hu, Yuyan Wang, Wenlin Ren, Xiaomin Zhao, Fansen Ji, et al. (+19)
429 [GO] 2021―Feb―26 Reply to Kuśmierz and Toyoizumi: A network-based explanation of why most COVID-19 infection curves are linear Stefan Thurner, Peter Klimek, Rudolf Hanel
430 [GO] 2021―Feb―26 Retail store customer flow and COVID-19 transmission Robert A. Shumsky, Laurens Debo, Rebecca M. Lebeaux, Quang P. Nguyen, Anne G. Hoen
431 [GO] 2021―Feb―26 Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored Weilong Ji, Xue Li, Si Chen, Linzhu Ren
432 [GO] 2021―Feb―25 Vaccinating the oldest against COVID-19 saves both the most lives and most years of life Joshua R. Goldstein, Thomas Cassidy, Kenneth W. Wachter
433 [GO] 2021―Feb―24 Monitoring epidemics: Lessons from measuring population prevalence of the coronavirus Samuel J. Clark, Abigail Norris Turner
434 [GO] 2021―Feb―22 Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance Robert M. Kaplan, Arnold Milstein
435 [GO] 2021―Feb―17 Bepridil is potent against SARS-CoV-2 in vitro Erol C. Vatansever, Kai S. Yang, Aleksandra K. Drelich, Kaci C. Kratch, Chia-Chuan Cho, Kempaiah Rayavara Kempaiah, et al. (+5)
436 [GO] 2021―Feb―16 A genomic region associated with protection against severe COVID-19 is inherited from Neandertals Hugo Zeberg, Svante Pääbo
437 [GO] 2021―Feb―13 The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 Donald J. Benton, Antoni G. Wrobel, Chloë Roustan, Annabel Borg, Pengqi Xu, Stephen R. Martin, et al. (+3)
438 [GO] 2021―Feb―11 The effects of school closures on SARS-CoV-2 among parents and teachers Jonas Vlachos, Edvin Hertegård, Helena B. Svaleryd
439 [GO] 2021―Feb―10 Lifestyle and mental health disruptions during COVID-19 Osea Giuntella, Kelly Hyde, Silvia Saccardo, Sally Sadoff
440 [GO] 2021―Feb―10 Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity Rahul Subramanian, Qixin He, Mercedes Pascual
441 [GO] 2021―Feb―10 The origin and early spread of SARS-CoV-2 in Europe Sarah A. Nadeau, Timothy G. Vaughan, Jérémie Scire, Jana S. Huisman, Tanja Stadler
442 [GO] 2021―Feb―10 Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors Chunlong Ma, Jun Wang
443 [GO] 2021―Feb―10 Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors Zhe Li, Yuxi Lin, Yi-You Huang, Runduo Liu, Chang-Guo Zhan, Xin Wang, Hai-Bin Luo
444 [GO] 2021―Feb―09 Exhaled aerosol increases with COVID-19 infection, age, and obesity David A. Edwards, Dennis Ausiello, Jonathan Salzman, Tom Devlin, Robert Langer, Brandon J. Beddingfield, et al. (+6)
445 [GO] 2021―Feb―08 Correction for Cippà et al., A data-driven approach to identify risk profiles and protective drugs in COVID-19
446 [GO] 2021―Feb―06 Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland Brea L. Perry, Brian Aronson, Bernice A. Pescosolido
447 [GO] 2021―Feb―04 Social distancing decreases an individual’s likelihood of contracting COVID-19 Russell H. Fazio, Benjamin C. Ruisch, Courtney A. Moore, Javier A. Granados Samayoa, Shelby T. Boggs, Jesse T. Ladanyi
448 [GO] 2021―Feb―03 Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission Parham Azimi, Zahra Keshavarz, Jose Guillermo Cedeno Laurent, Brent Stephens, Joseph G. Allen
449 [GO] 2021―Feb―03 Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, Jade Ghosn, Ilka Engelmann, Quentin Lepiller, et al. (+28)
450 [GO] 2021―Feb―02 COVID-19 gender policy changes support female scientists and improve research quality Holly O. Witteman, Jenna Haverfield, Cara Tannenbaum
451 [GO] 2021―Feb―02 Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States Gerard Torrats-Espinosa
452 [GO] 2021―Feb―01 Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP Katerina Naydenova, Kyle W. Muir, Long-Fei Wu, Ziguo Zhang, Francesca Coscia, Mathew J. Peet, et al. (+9)
453 [GO] 2021―Jan―21 Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity Egle Kvedaraite, Laura Hertwig, Indranil Sinha, Andrea Ponzetta, Ida Hed Myrberg, Magda Lourda, et al. (+18)
454 [GO] 2021―Jan―21 Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation Christopher P. Lapointe, Rosslyn Grosely, Alex G. Johnson, Jinfan Wang, Israel S. Fernández, Joseph D. Puglisi
455 [GO] 2021―Jan―20 Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit Heiko Slanina, Ramakanth Madhugiri, Ganesh Bylapudi, Karin Schultheiß, Nadja Karl, Anastasia Gulyaeva, et al. (+3)
456 [GO] 2021―Jan―20 Rational policymaking during a pandemic Loïc Berger, Nicolas Berger, Valentina Bosetti, Itzhak Gilboa, Lars Peter Hansen, Christopher Jarvis, et al. (+2)
457 [GO] 2021―Jan―20 The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome B. Brett Finlay, Katherine R. Amato, Meghan Azad, Martin J. Blaser, Thomas C. G. Bosch, Hiutung Chu, et al. (+17)
458 [GO] 2021―Jan―19 The joint dynamics of investor beliefs and trading during the COVID-19 crash Stefano Giglio, Matteo Maggiori, Johannes Stroebel, Stephen Utkus
459 [GO] 2021―Jan―15 Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection Jia-Tsrong Jan, Ting-Jen Rachel Cheng, Yu-Pu Juang, Hsiu-Hua Ma, Ying-Ta Wu, Wen-Bin Yang, et al. (+11)
460 [GO] 2021―Jan―14 Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations Theresa Andrasfay, Noreen Goldman
461 [GO] 2021―Jan―14 Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset Varun Sasisekharan, Niharika Pentakota, Akila Jayaraman, Kannan Tharakaraman, Gerald N. Wogan, Uma Narayanasami
462 [GO] 2021―Jan―13 Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing Constantin T. Yiannoutsos, Paul K. Halverson, Nir Menachemi
463 [GO] 2021―Jan―12 An evidence review of face masks against COVID-19 Jeremy Howard, Austin Huang, Zhiyuan Li, Zeynep Tufekci, Vladimir Zdimal, Helene-Mari van der Westhuizen, et al. (+13)
464 [GO] 2021―Jan―08 On COVID-19, cognitive bias, and open access May R. Berenbaum
465 [GO] 2021―Jan―07 Retrospective analysis of the Italian exit strategy from COVID-19 lockdown Valentina Marziano, Giorgio Guzzetta, Bruna Maria Rondinone, Fabio Boccuni, Flavia Riccardo, Antonino Bella, et al. (+8)
466 [GO] 2021―Jan―05 In silico dynamics of COVID-19 phenotypes for optimizing clinical management Chrysovalantis Voutouri, Mohammad Reza Nikmaneshi, C. Corey Hardin, Ankit B. Patel, Ashish Verma, Melin J. Khandekar, et al. (+4)
467 [GO] 2021―Jan―04 Effect of “finite pool of worry” and COVID-19 on UK climate change perceptions Darrick Evensen, Lorraine Whitmarsh, Phil Bartie, Patrick Devine-Wright, Jennifer Dickie, Adam Varley, et al. (+2)
468 [GO] 2021―Jan―04 ADP-ribose and analogues bound to the deMARylating macrodomain from the bat coronavirus HKU4 Robert G. Hammond, Norbert Schormann, Robert Lyle McPherson, Anthony K. L. Leung, Champion C. S. Deivanayagam, Margaret A. Johnson
469 [GO] 2020―Dec―23 Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas Haesung Jung, Dolores Albarracín
470 [GO] 2020―Dec―23 Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society Katrin Schmelz
471 [GO] 2020―Dec―23 Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein Thomas G. Flower, Cosmo Z. Buffalo, Richard M. Hooy, Marc Allaire, Xuefeng Ren, James H. Hurley
472 [GO] 2020―Dec―23 Cross-species recognition of SARS-CoV-2 to bat ACE2 Kefang Liu, Shuguang Tan, Sheng Niu, Jia Wang, Lili Wu, Huan Sun, et al. (+13)
473 [GO] 2020―Dec―17 Nursing home staff networks and COVID-19 M. Keith Chen, Judith A. Chevalier, Elisa F. Long
474 [GO] 2020―Dec―17 Global evidence for ultraviolet radiation decreasing COVID-19 growth rates Tamma Carleton, Jules Cornetet, Peter Huybers, Kyle C. Meng, Jonathan Proctor
475 [GO] 2020―Dec―17 Impacts of the COVID-19 pandemic on rural America J. Tom Mueller, Kathryn McConnell, Paul Berne Burow, Katie Pofahl, Alexis A. Merdjanoff, Justin Farrell
476 [GO] 2020―Dec―11 The spread of COVID-19 shows the importance of policy coordination Joshua Graff Zivin, Nicholas Sanders
477 [GO] 2020―Dec―11 Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 Yuanyuan Qiao, Xiao-Ming Wang, Rahul Mannan, Sethuramasundaram Pitchiaya, Yuping Zhang, Jesse W. Wotring, et al. (+25)
478 [GO] 2020―Dec―10 A data-driven approach to identify risk profiles and protective drugs in COVID-19 Pietro E. Cippà, Federica Cugnata, Paolo Ferrari, Chiara Brombin, Lorenzo Ruinelli, Giorgia Bianchi, et al. (+6)
479 [GO] 2020―Dec―04 Face masks considerably reduce COVID-19 cases in Germany Timo Mitze, Reinhold Kosfeld, Johannes Rode, Klaus Wälde
480 [GO] 2020―Dec―04 COVID-19 lockdown induces disease-mitigating structural changes in mobility networks Frank Schlosser, Benjamin F. Maier, Olivia Jack, David Hinrichs, Adrian Zachariae, Dirk Brockmann
481 [GO] 2020―Dec―01 A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine Cindy Hörner, Christoph Schürmann, Arne Auste, Aileen Ebenig, Samada Muraleedharan, Kenneth H. Dinnon, et al. (+5)
482 [GO] 2020―Nov―25 Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion Ruochen Zang, James Brett Case, Eylan Yutuc, Xiucui Ma, Sheng Shen, Maria Florencia Gomez Castro, et al. (+21)
483 [GO] 2020―Nov―20 Event-specific interventions to minimize COVID-19 transmission Paul Tupper, Himani Boury, Madi Yerlanov, Caroline Colijn
484 [GO] 2020―Nov―20 Livestock plants and COVID-19 transmission Charles A. Taylor, Christopher Boulos, Douglas Almond
485 [GO] 2020―Nov―18 Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions? Yong Wang, Qing Mao, Xiangdong Zhou
486 [GO] 2020―Nov―17 Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges Krishna Sriram, Rohit Loomba, Paul A. Insel
487 [GO] 2020―Nov―17 Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes Hong-Li Zeng, Vito Dichio, Edwin Rodríguez Horta, Kaisa Thorell, Erik Aurell
488 [GO] 2020―Nov―13 Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients Chengliang Yang, Elizabeth Liu, Mingyao Liu
489 [GO] 2020―Nov―13 Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, et al. (+7)
490 [GO] 2020―Nov―13 The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses Stuart Weston, Lauren Baracco, Chloe Keller, Krystal Matthews, Marisa E. McGrath, James Logue, et al. (+8)
491 [GO] 2020―Nov―13 Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations Hsin-Chou Yang, Chun-houh Chen, Jen-Hung Wang, Hsiao-Chi Liao, Chih-Ting Yang, Chia-Wei Chen, et al. (+4)
492 [GO] 2020―Nov―12 Network interventions for managing the COVID-19 pandemic and sustaining economy Akihiro Nishi, George Dewey, Akira Endo, Sophia Neman, Sage K. Iwamoto, Michael Y. Ni, et al. (+4)
493 [GO] 2020―Nov―12 In fatal COVID-19, the immune response can control the virus but kill the patient Arturo Casadevall, Liise-anne Pirofski
494 [GO] 2020―Nov―10 The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections Rachel E. Baker, Sang Woo Park, Wenchang Yang, Gabriel A. Vecchi, C. Jessica E. Metcalf, Bryan T. Grenfell
495 [GO] 2020―Nov―10 The interplay of movement and spatiotemporal variation in transmission degrades pandemic control Nicholas Kortessis, Margaret W. Simon, Michael Barfield, Gregory E. Glass, Burton H. Singer, Robert D. Holt
496 [GO] 2020―Nov―05 Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2 Ashwin Ramachandran, Diego A. Huyke, Eesha Sharma, Malaya K. Sahoo, ChunHong Huang, Niaz Banaei, et al. (+2)
497 [GO] 2020―Nov―03 Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19 David A. Relman
498 [GO] 2020―Nov―03 Correction for Goldstein and Lee, Demographic perspectives on the mortality of COVID-19 and other epidemics
499 [GO] 2020―Nov―03 COVID-19 pandemic impacts on global inland fisheries Gretchen L. Stokes, Abigail J. Lynch, Benjamin S. Lowe, Simon Funge-Smith, John Valbo-Jørgensen, Samuel J. Smidt
500 [GO] 2020―Nov―03 Evidence that coronavirus superspreading is fat-tailed Felix Wong, James J. Collins
501 [GO] 2020―Nov―03 Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection Wei Li, Chuan Chen, Aleksandra Drelich, David R. Martinez, Lisa E. Gralinski, Zehua Sun, et al. (+14)
502 [GO] 2020―Oct―29 Opinion: For now, it’s unethical to use human challenge studies for SARS-CoV-2 vaccine development Jeffrey P. Kahn, Leslie Meltzer Henry, Anna C. Mastroianni, Wilbur H. Chen, Ruth Macklin
503 [GO] 2020―Oct―24 SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling Lisa Miorin, Thomas Kehrer, Maria Teresa Sanchez-Aparicio, Ke Zhang, Phillip Cohen, Roosheel S. Patel, et al. (+21)
504 [GO] 2020―Oct―23 Engineered ACE2 receptor traps potently neutralize SARS-CoV-2 Anum Glasgow, Jeff Glasgow, Daniel Limonta, Paige Solomon, Irene Lui, Yang Zhang, et al. (+14)
505 [GO] 2020―Oct―23 The pandemic exposes human nature: 10 evolutionary insights Benjamin M. Seitz, Athena Aktipis, David M. Buss, Joe Alcock, Paul Bloom, Michele Gelfand, et al. (+6)
506 [GO] 2020―Oct―22 Opinion: A risk-benefit framework for human research during the COVID-19 pandemic Julie C. Lumeng, Tabbye M. Chavous, Anna S. Lok, Srijan Sen, Nicholas S. Wigginton, Rebecca M. Cunningham
507 [GO] 2020―Oct―22 Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data Elie Dolgin
508 [GO] 2020―Oct―20 Transcriptional and proteomic insights into the host response in fatal COVID-19 cases Meng Wu, Yaobing Chen, Han Xia, Changli Wang, Chin Yee Tan, Xunhui Cai, et al. (+20)
509 [GO] 2020―Oct―20 Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts Maria Polyakova, Geoffrey Kocks, Victoria Udalova, Amy Finkelstein
510 [GO] 2020―Oct―20 Acceleration of plague outbreaks in the second pandemic David J. D. Earn, Junling Ma, Hendrik Poinar, Jonathan Dushoff, Benjamin M. Bolker
511 [GO] 2020―Oct―15 Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries Vincenzo Galasso, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard, Martial Foucault
512 [GO] 2020―Oct―15 Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections Chenfeng Xiong, Songhua Hu, Mofeng Yang, Weiyu Luo, Lei Zhang
513 [GO] 2020―Oct―13 Correction for Escobar et al., BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
514 [GO] 2020―Oct―13 Economic hardship and mental health complaints during COVID-19 Dirk Witteveen, Eva Velthorst
515 [GO] 2020―Oct―13 Seasonality and uncertainty in global COVID-19 growth rates Cory Merow, Mark C. Urban
516 [GO] 2020―Oct―13 Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection Caitlin E. Edwards, Boyd L. Yount, Rachel L. Graham, Sarah R. Leist, Yixuan J. Hou, Kenneth H. Dinnon, et al. (+8)
517 [GO] 2020―Oct―13 Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs Zhe Li, Xin Li, Yi-You Huang, Yaoxing Wu, Runduo Liu, Lingli Zhou, et al. (+11)
518 [GO] 2020―Oct―09 Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries, Laura Seldeslachts, Sebastiaan ter Horst, Laurens Liesenborghs, et al. (+29)
519 [GO] 2020―Oct―07 Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases Michael K. Lo, César G. Albariño, Jason K. Perry, Silvia Chang, Egor P. Tchesnokov, Lisa Guerrero, et al. (+12)
520 [GO] 2020―Oct―06 Correction for Zhang et al., Identifying airborne transmission as the dominant route for the spread of COVID-19
521 [GO] 2020―Oct―06 Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines Lang Rao, Shuai Xia, Wei Xu, Rui Tian, Guocan Yu, Chenjian Gu, et al. (+8)
522 [GO] 2020―Oct―01 Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer Amy McDermott
523 [GO] 2020―Sep―30 Lack of evidence for BCG vaccine protection from severe COVID-19 Cecilia S. Lindestam Arlehamn, Alessandro Sette, Bjoern Peters
524 [GO] 2020―Sep―30 Dangerous to claim “no clear association” between intergenerational relationships and COVID-19 Jennifer Beam Dowd, Per Block, Valentina Rotondi, Melinda C. Mills
525 [GO] 2020―Sep―30 The bacillus Calmette-Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infection Vincenzo Patella, Gabriele Delfino, Dario Bruzzese, Ada Giuliano, Alessandro Sanduzzi
526 [GO] 2020―Sep―30 Reply to Dowd et al.: Dangerous to overemphasize the importance of specific COVID-19 risk factors based on (unadjusted) macro-level analyses Bruno Arpino, Valeria Bordone, Marta Pasqualini
527 [GO] 2020―Sep―29 Global COVID-19 pandemic demands joint interventions for the suppression of future waves Ruiyun Li, Bin Chen, Tao Zhang, Zhehao Ren, Yimeng Song, Yixiong Xiao, et al. (+25)
528 [GO] 2020―Sep―29 Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guérin (BCG) vaccination on COVID-19 prevalence and mortality Carolina Barillas-Mury, Luis E. Escobar, Alvaro Molina-Cruz
529 [GO] 2020―Sep―29 Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity Yifei Lang, Wentao Li, Zeshi Li, Danielle Koerhuis, Arthur C. S. van den Burg, Erik Rozemuller, et al. (+6)
530 [GO] 2020―Sep―29 Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation Mary Hongying Cheng, She Zhang, Rebecca A. Porritt, Magali Noval Rivas, Lisa Paschold, Edith Willscher, et al. (+3)
531 [GO] 2020―Sep―29 Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats Angela M. Bosco-Lauth, Airn E. Hartwig, Stephanie M. Porter, Paul W. Gordy, Mary Nehring, Alex D. Byas, et al. (+4)
532 [GO] 2020―Sep―25 The rise of COVID-19 cases is associated with support for world leaders Kai Chi Yam, Joshua Conrad Jackson, Christopher M. Barnes, Jenson Lau, Xin Qin, Hin Yeung Lee
533 [GO] 2020―Sep―25 Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City Bryan Wilder, Marie Charpignon, Jackson A. Killian, Han-Ching Ou, Aditya Mate, Shahin Jabbari, et al. (+4)
534 [GO] 2020―Sep―22 America’s electorate is increasingly polarized along partisan lines about voting by mail during the COVID-19 crisis Mackenzie Lockhart, Seth J. Hill, Jennifer Merolla, Mindy Romero, Thad Kousser
535 [GO] 2020―Sep―22 Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies Tobias S. Brett, Pejman Rohani
536 [GO] 2020―Sep―22 Low genetic diversity may be an Achilles heel of SARS-CoV-2 Jason W. Rausch, Adam A. Capoferri, Mary Grace Katusiime, Sean C. Patro, Mary F. Kearney
537 [GO] 2020―Sep―18 Don’t let COVID-19 disrupt campus climate surveys of sexual harassment Kathryn J. Holland, Lilia M. Cortina, Vicki J. Magley, Arielle L. Baker, Frazier F. Benya
538 [GO] 2020―Sep―18 Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients Jan C. Holter, Soeren E. Pischke, Eline de Boer, Andreas Lind, Synne Jenum, Aleksander R. Holten, et al. (+26)
539 [GO] 2020―Sep―18 Using the curriculum vitae to promote gender equity during the COVID-19 pandemic Vineet M. Arora, Charles M. Wray, Avital Y. O’Glasser, Mark Shapiro, Shikha Jain
540 [GO] 2020―Sep―18 Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain Joaquim Segalés, Mariona Puig, Jordi Rodon, Carlos Avila-Nieto, Jorge Carrillo, Guillermo Cantero, et al. (+12)
541 [GO] 2020―Sep―15 Political partisanship influences behavioral responses to governors’ recommendations for COVID-19 prevention in the United States Guy Grossman, Soojong Kim, Jonah M. Rexer, Harsha Thirumurthy
542 [GO] 2020―Sep―15 Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection Alan Sariol, Samantha Mackin, Merri-Grace Allred, Chen Ma, Yu Zhou, Qinran Zhang, et al. (+4)
543 [GO] 2020―Sep―10 Spatial heterogeneity can lead to substantial local variations in COVID-19 timing and severity Loring J. Thomas, Peng Huang, Fan Yin, Xiaoshuang Iris Luo, Zack W. Almquist, John R. Hipp, Carter T. Butts
544 [GO] 2020―Sep―10 Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype Jennifer R. Habel, Thi H. O. Nguyen, Carolien E. van de Sandt, Jennifer A. Juno, Priyanka Chaurasia, Kathleen Wragg, et al. (+19)
545 [GO] 2020―Sep―08 SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification Brian A. Rabe, Constance Cepko
546 [GO] 2020―Sep―08 Correction to Supporting Information for Sun et al., Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection
547 [GO] 2020―Sep―04 Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve Vadim A. Karatayev, Madhur Anand, Chris T. Bauch
548 [GO] 2020―Sep―03 Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics Jonathan Baruch Steinman, Fok Moon Lum, Peggy Pui-Kay Ho, Naftali Kaminski, Lawrence Steinman
549 [GO] 2020―Sep―01 Correction for Cauchois et al., Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
550 [GO] 2020―Sep―01 Rapid isothermal amplification and portable detection system for SARS-CoV-2 Anurup Ganguli, Ariana Mostafa, Jacob Berger, Mehmet Y. Aydin, Fu Sun, Sarah A. Stewart de Ramirez, et al. (+4)
551 [GO] 2020―Sep―01 A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants Bethany Dearlove, Eric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, M. Gordon Joyce, et al. (+6)
552 [GO] 2020―Aug―25 US racial inequality may be as deadly as COVID-19 Elizabeth Wrigley-Field
553 [GO] 2020―Aug―25 A network-based explanation of why most COVID-19 infection curves are linear Stefan Thurner, Peter Klimek, Rudolf Hanel
554 [GO] 2020―Aug―21 Estimating unobserved SARS-CoV-2 infections in the United States T. Alex Perkins, Sean M. Cavany, Sean M. Moore, Rachel J. Oidtman, Anita Lerch, Marya Poterek
555 [GO] 2020―Aug―21 Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates Joana Damas, Graham M. Hughes, Kathleen C. Keough, Corrie A. Painter, Nicole S. Persky, Marco Corbo, et al. (+13)
556 [GO] 2020―Aug―20 Demographic perspectives on the mortality of COVID-19 and other epidemics Joshua R. Goldstein, Ronald D. Lee
557 [GO] 2020―Aug―20 Social and behavioral consequences of mask policies during the COVID-19 pandemic Cornelia Betsch, Lars Korn, Philipp Sprengholz, Lisa Felgendreff, Sarah Eitze, Philipp Schmid, Robert Böhm
558 [GO] 2020―Aug―20 The effect of big-city news on rural America during the COVID-19 pandemic Eunji Kim, Michael E. Shepherd, Joshua D. Clinton
559 [GO] 2020―Aug―20 Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA Max S. Y. Lau, Bryan Grenfell, Michael Thomas, Michael Bryan, Kristin Nelson, Ben Lopman
560 [GO] 2020―Aug―11 Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries Abiel Sebhatu, Karl Wennberg, Stefan Arora-Jonsson, Staffan I. Lindberg
561 [GO] 2020―Aug―11 Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom Mark Hamer, Catharine R. Gale, Mika Kivimäki, G. David Batty
562 [GO] 2020―Aug―06 Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2 Yuan-Lin Kang, Yi-ying Chou, Paul W. Rothlauf, Zhuoming Liu, Timothy K. Soh, David Cureton, et al. (+5)
563 [GO] 2020―Aug―04 Social distancing laws cause only small losses of economic activity during the COVID-19 pandemic in Scandinavia Adam Sheridan, Asger Lau Andersen, Emil Toft Hansen, Niels Johannesen
564 [GO] 2020―Jul―31 Interdependence and the cost of uncoordinated responses to COVID-19 David Holtz, Michael Zhao, Seth G. Benzell, Cathy Y. Cao, Mohammad Amin Rahimian, Jeremy Yang, et al. (+10)
565 [GO] 2020―Jul―30 Opinion: Here’s how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19 M. Bishr Omary, Mahmud Hassan
566 [GO] 2020―Jul―30 Social distancing responses to COVID-19 emergency declarations strongly differentiated by income Joakim A. Weill, Matthieu Stigler, Olivier Deschenes, Michael R. Springborn
567 [GO] 2020―Jul―30 Timing social distancing to avert unmanageable COVID-19 hospital surges Daniel Duque, David P. Morton, Bismark Singh, Zhanwei Du, Remy Pasco, Lauren Ancel Meyers
568 [GO] 2020―Jul―28 COVID-19 lockdowns cause global air pollution declines Zander S. Venter, Kristin Aunan, Sourangsu Chowdhury, Jos Lelieveld
569 [GO] 2020―Jul―28 Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak Tsuyoshi Sekizuka, Kentaro Itokawa, Tsutomu Kageyama, Shinji Saito, Ikuyo Takayama, Hideki Asanuma, et al. (+11)
570 [GO] 2020―Jul―23 Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19 Raphaël Cauchois, Marie Koubi, David Delarbre, Cécile Manet, Julien Carvelli, Valery Benjamin Blasco, et al. (+9)
571 [GO] 2020―Jul―23 No clear association emerges between intergenerational relationships and COVID-19 fatality rates from macro-level analyses Bruno Arpino, Valeria Bordone, Marta Pasqualini
572 [GO] 2020―Jul―23 Opinion: It’s ethical to test promising coronavirus vaccines against less-promising ones Nir Eyal, Marc Lipsitch
573 [GO] 2020―Jul―11 Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States Ashton M. Verdery, Emily Smith-Greenaway, Rachel Margolis, Jonathan Daw
574 [GO] 2020―Jul―11 The impact of COVID-19 on small business outcomes and expectations Alexander W. Bartik, Marianne Bertrand, Zoe Cullen, Edward L. Glaeser, Michael Luca, Christopher Stanton
575 [GO] 2020―Jul―11 Working memory capacity predicts individual differences in social-distancing compliance during the COVID-19 pandemic in the United States Weizhen Xie, Stephen Campbell, Weiwei Zhang
576 [GO] 2020―Jul―09 BCG vaccine protection from severe coronavirus disease 2019 (COVID-19) Luis E. Escobar, Alvaro Molina-Cruz, Carolina Barillas-Mury
577 [GO] 2020―Jul―07 The implications of silent transmission for the control of COVID-19 outbreaks Seyed M. Moghadas, Meagan C. Fitzpatrick, Pratha Sah, Abhishek Pandey, Affan Shoukat, Burton H. Singer, Alison P. Galvani
578 [GO] 2020―Jul―03 The challenges of modeling and forecasting the spread of COVID-19 Andrea L. Bertozzi, Elisa Franco, George Mohler, Martin B. Short, Daniel Sledge
579 [GO] 2020―Jun―30 Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection Honglei Sun, Yihong Xiao, Jiyu Liu, Dayan Wang, Fangtao Li, Chenxi Wang, et al. (+17)
580 [GO] 2020―Jun―24 Opinion: What models can and cannot tell us about COVID-19 Alexander F. Siegenfeld, Nassim N. Taleb, Yaneer Bar-Yam
581 [GO] 2020―Jun―24 Correcting misperceptions of exponential coronavirus growth increases support for social distancing Joris Lammers, Jan Crusius, Anne Gast
582 [GO] 2020―Jun―23 Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden Marília R. Nepomuceno, Enrique Acosta, Diego Alburez-Gutierrez, José Manuel Aburto, Alain Gagnon, Cássio M. Turra
583 [GO] 2020―Jun―23 Reply to Nepomuceno et al.: A renewed call for detailed social and demographic COVID-19 data from all countries Jennifer Beam Dowd, Liliana Andriano, David M. Brazel, Valentina Rotondi, Per Block, Xuejie Ding, Melinda C. Mills
584 [GO] 2020―Jun―23 National age and coresidence patterns shape COVID-19 vulnerability Albert Esteve, Iñaki Permanyer, Diederik Boertien, James W. Vaupel
585 [GO] 2020―Jun―23 Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS Ruangang Pan, Qinran Zhang, Scott M. Anthony, Yu Zhou, Xiufen Zou, Martin Cassell, Stanley Perlman
586 [GO] 2020―Jun―23 Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Masaki Imai, Kiyoko Iwatsuki-Horimoto, Masato Hatta, Samantha Loeber, Peter J. Halfmann, Noriko Nakajima, et al. (+28)
587 [GO] 2020―Jun―18 Economic and social consequences of human mobility restrictions under COVID-19 Giovanni Bonaccorsi, Francesco Pierri, Matteo Cinelli, Andrea Flori, Alessandro Galeazzi, Francesco Porcelli, et al. (+5)
588 [GO] 2020―Jun―17 Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity Jessica L. Malisch, Breanna N. Harris, Shanen M. Sherrer, Kristy A. Lewis, Stephanie L. Shepherd, Pumtiwitt C. McCarthy, et al. (+11)
589 [GO] 2020―Jun―11 Identifying airborne transmission as the dominant route for the spread of COVID-19 Renyi Zhang, Yixin Li, Annie L. Zhang, Yuan Wang, Mario J. Molina
590 [GO] 2020―Jun―11 Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations Seth G. Benzell, Avinash Collis, Christos Nicolaides
591 [GO] 2020―Jun―11 Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses Ayal B. Gussow, Noam Auslander, Guilhem Faure, Yuri I. Wolf, Feng Zhang, Eugene V. Koonin
592 [GO] 2020―Jun―05 Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions Yingjie Wang, Meiyi Liu, Jiali Gao
593 [GO] 2020―Jun―03 Opinion: Intercepting pandemics through genomics W. John Kress, Jonna A. K. Mazet, Paul D. N. Hebert
594 [GO] 2020―May―22 Reply to Sánchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes Peter Forster, Lucy Forster, Colin Renfrew, Michael Forster
595 [GO] 2020―May―19 Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic Ethan J. Raker, Meghan Zacher, Sarah R. Lowe
596 [GO] 2020―May―14 The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission Valentyn Stadnytskyi, Christina E. Bax, Adriaan Bax, Philip Anfinrud
597 [GO] 2020―May―12 Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19 Selman Kesici, Sinan Yavuz, Benan Bayrakci
598 [GO] 2020―May―12 Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19 Kai Duan, Bende Liu, Cesheng Li, Huajun Zhang, Ting Yu, Jieming Qu, et al. (+5)
599 [GO] 2020―May―12 Convalescent plasma for patients with COVID-19 Furong Zeng, Xiang Chen, Guangtong Deng
600 [GO] 2020―May―08 Evolving COVID-19 conundrum and its impact Thanat Chookajorn
601 [GO] 2020―May―08 Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary Santiago J. Sánchez-Pacheco, Sungsik Kong, Paola Pulido-Santacruz, Robert W. Murphy, Laura Kubatko
602 [GO] 2020―May―08 Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable Carla Mavian, Sergei Kosakovsky Pond, Simone Marini, Brittany Rife Magalis, Anne-Mieke Vandamme, Simon Dellicour, et al. (+30)
603 [GO] 2020―May―06 Cell entry mechanisms of SARS-CoV-2 Jian Shang, Yushun Wan, Chuming Luo, Gang Ye, Qibin Geng, Ashley Auerbach, Fang Li
604 [GO] 2020―May―05 Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases Ana I. Bento, Thuy Nguyen, Coady Wing, Felipe Lozano-Rojas, Yong-Yeol Ahn, Kosali Simon
605 [GO] 2020―Apr―29 Effective treatment of severe COVID-19 patients with tocilizumab Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, et al. (+7)
606 [GO] 2020―Apr―29 News Feature: To counter the pandemic, clinicians bank on repurposed drugs Jyoti Madhusoodanan
607 [GO] 2020―Apr―23 Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures Marino Gatto, Enrico Bertuzzo, Lorenzo Mari, Stefano Miccoli, Luca Carraro, Renato Casagrandi, Andrea Rinaldo
608 [GO] 2020―Apr―16 Inner Workings: Molecular biologists offer “wartime service” in the effort to test for COVID-19 Amy McDermott
609 [GO] 2020―Apr―16 Demographic science aids in understanding the spread and fatality rates of COVID-19 Jennifer Beam Dowd, Liliana Andriano, David M. Brazel, Valentina Rotondi, Per Block, Xuejie Ding, et al. (+2)
610 [GO] 2020―Apr―11 PNAS and the pandemic May R. Berenbaum
611 [GO] 2020―Apr―09 Phylogenetic network analysis of SARS-CoV-2 genomes Peter Forster, Lucy Forster, Colin Renfrew, Michael Forster
612 [GO] 2020―Apr―07 Effectiveness of convalescent plasma therapy in severe COVID-19 patients Kai Duan, Bende Liu, Cesheng Li, Huajun Zhang, Ting Yu, Jieming Qu, et al. (+42)
613 [GO] 2020―Apr―03 Projecting hospital utilization during the COVID-19 outbreaks in the United States Seyed M. Moghadas, Affan Shoukat, Meagan C. Fitzpatrick, Chad R. Wells, Pratha Sah, Abhishek Pandey, et al. (+5)
614 [GO] 2020―Mar―31 News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine Lynne Peeples
615 [GO] 2020―Mar―20 Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors Matthew Hackbart, Xufang Deng, Susan C. Baker
616 [GO] 2020―Mar―14 Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak Chad R. Wells, Pratha Sah, Seyed M. Moghadas, Abhishek Pandey, Affan Shoukat, Yaning Wang, et al. (+4)
617 [GO] 2020―Mar―12 Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells Shutoku Matsuyama, Naganori Nao, Kazuya Shirato, Miyuki Kawase, Shinji Saito, Ikuyo Takayama, et al. (+12)
618 [GO] 2020―Mar―10 Molecular recognition of a host protein by NS1 of pandemic and seasonal influenza A viruses Jae-Hyun Cho, Baoyu Zhao, Jie Shi, Nowlan Savage, Qingliang Shen, James Byrnes, et al. (+3)
619 [GO] 2020―Feb―15 Opinion: Sustainable development must account for pandemic risk Moreno Di Marco, Michelle L. Baker, Peter Daszak, Paul De Barro, Evan A. Eskew, Cecile M. Godde, et al. (+12)
620 [GO] 2020―Feb―14 Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection Emmie de Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, et al. (+3)
621 [GO] 2020―Jan―04 Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans Tzu-Jing Yang, Yen-Chen Chang, Tzu-Ping Ko, Piotr Draczkowski, Yu-Chun Chien, Yuan-Chih Chang, et al. (+4)
622 [GO] 2019―Dec―03 The Justinianic Plague: An inconsequential pandemic? Lee Mordechai, Merle Eisenberg, Timothy P. Newfield, Adam Izdebski, Janet E. Kay, Hendrik Poinar
 [1] 

622 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.041 sec